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Abstract 
The developmental transitions occurring during embryogenesis involve spatial 
and temporal changes in gene expression patterns, which are largely 
dependent on a group of regulatory elements known as enhancers. Enhancers 
are short DNA sequences able to positively control the expression of their 
target genes in a distance and orientation independent manner. Previous 
studies uncovered a unique set of enhancers in pluripotent embryonic stem 
cells (ESCs), named “Poised Enhancers”. Poised enhancers are marked by 
repressive histone marks, like the trimethylation of histone three lysine 27, 
which is deposited by Polycomb repressive complex 2 (PRC2), and also are 
bound by co-activators like P300. The fact that poised enhancers display both 
activating and repressing features as well as evidences indicating that they are 
associated with genes involved in early organogenesis led us to suggest that 
these regulatory elements are already bookmarked in ESCs and thus primed 
for their future activation once the differentiation process starts. However, the 
functional relevance of poised enhancers and the role of their unique chromatin 
features remain unknown. 
To gain insights into these major questions, first, poised enhancers were 
identified in mouse embryonic stem cells (mESCs) and their activation was 
evaluated during the establishment of anterior neural identity. Second, using 
CRISPR/Cas9 technology, poised enhancer candidates were deleted in 
mESCs, which were then differentiated into anterior neural progenitors. In 
general, the poised enhancer deletions resulted in severely reduced induction 
of the poised enhancer’s target genes. Furthermore, circularized chromosome 
conformation capture coupled to sequencing experiments revealed that poised 
enhancers and their target genes physically interacted already in ESCs, thus 
preceding the activation of poised enhancers and their target genes. 
Interestingly, these poised enhancer-target gene interactions observed in 
mESCs were found to be PRC2 dependent. Additionally, it was demonstrated 
that while PRC2 was not necessary to maintain poised enhancers in an 
inactive state in mESCs, was required for the induction of the poised 
enhancers’ target genes upon anterior neural differentiation. Finally, poised 
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enhancers were found to frequently reside within a high CpG-dinucleotide 
genomic context that can directly mediate the recruitment of PRC2. 
Overall, these findings demonstrate that poised enhancers are essential for the 
proper expression of the anterior neural developmental program. Importantly, 
our work illuminates an unexpected function for PRC2 in promoting neural 
induction. Our data demonstrates that both poised enhancers and their target 
genes display intrinsic sequence features that can directly mediate PRC2 
recruitment. Consequently, PRC2 can bring poised enhancers and their targets 
into physical proximity already in mESCs, thus providing a permissive 
regulatory topology that we propose can facilitate the future induction of mayor 
anterior neural genes. 
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Zusammenfassung 
Die Entwicklungsphasen während der Embryogenese werden durch räumliche 
und zeitliche Veränderungen in den Genexpressionsmustern bestimmt, die 
stark von bestimmten Enhancern reguliert werden. Enhancer sind kurze DNA 
Sequenzen, die in der Lage sind die Expression von Genen unabhängig von 
Distanz und Orientierung positiv zu beeinflussen. Einige Studien haben bereits 
eine spezielle Gruppe von Enhancern in pluripotenten embryonischen 
Stammzellen (ESC) identifiziert, die "Poised Enhancers" (PE) genannt werden. 
PE sind durch repressive Histone-Markierungen, wie z.B., die 
Trimethylatisierung von Histone-3-Lysine-27 (H3K27me3) gekennzeichnet, 
welche durch den Polycomb-Repressive-Complex-2 (PRC2) angebracht 
werden. Gleichzeitig werden sie aber auch durch Co-Aktivatoren wie P300 
markiert. Da die PE‘s gleichzeitig aktivierende und repressive Eigenschaften 
aufweisen und mit bestimmten Genen assoziiert sind, die in der frühen 
Embryogenese aktiv sind, liegt die Vermutung nahe, dass sie in den ESC 
vormarkiert werden, um für eine bevorstehende Aktivierung bei einer 
anstehenden Differenzierung bereit zu sein. Die funktionelle Relevanz der PE‘s 
und die Rolle ihrer einzigartigen Chromatin Eigenschaften sind bisher noch 
ungeklärt. 
Um diese wichtigen Fragen beantworten zu können, wurden in dieser Arbeit 
zuerst geeignete PE-Kandidaten in Maus-ESC‘s (mESC‘s) identifiziert und ihre 
Aktivierung während der frühen neuronalen Entwicklung evaluiert. Zweitens, 
wurden exemplarisch einige PE-Kandidaten mit Hilfe des CRISPR-Cas9-
Systems in mESC entfernt, welche anschließend in anteriore neuronale 
Vorläuferzellen differenziert wurden (AntNPC). Alle hier erzielten Deletionen 
der PE führten zu einer stark reduzierten Induktion der PE-Zielgene in den 
AntNPC. Darüber hinaus zeigten 4C-seq-Experimente, dass PE und ihre 
Zielgene nicht nur in AntNPC, sondern auch in ESC, d.h. vor der Aktivierung 
der PE und ihrer Zielgene physikalisch interagieren. Interessanterweise konnte 
auch nachgewiesen werden, dass die Interaktionen der PE mit ihren Zielgenen 
von PRC2 abhängig sind. Außerdem wurde hier festgestellt, dass PRC2 nicht 
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notwendig ist, um die PE‘s in den mESC inaktiv zu halten, jedoch für die 
Aktivierung des PE-Zielgens während der AntNPC Differenzierung notwendig 
ist. Anschließend wurde gezeigt, dass PE‘s oft mit einem hohen CpG-
dinucleotide Genkontext auftreten, die mit der Rekrutierung von PRC2 in 
Verbindung stehen. 
Zusammenfassend zeigen die hier gezeigten Ergebnisse, dass die PE‘s 
essenziell für eine normale Expression des vorangehenden neuralen 
Entwicklungsprogramms sind. Die Daten demonstrieren auch, dass beide, die 
PE und ihre Zielgene, intrinsische Sequenzeigenschaften besitzen, welche die 
PRC2-Rekrutierung beeinflussen. Dementsprechend kann PRC2 die PE‘s und 
ihre Zielgene bereits in mESC in physikalische Nähe zueinander bringen und 
so eine permissive regulatorische Topologie bereitstellen, welche die 
zukünftige Induktion der anterioren neuronalen Vorläufergene erlaubt. 
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1- INTRODUCTION 
 
1.1- In vitro modeling of in vivo embryogenesis 
 
Embryogenesis is the process of cell division and cellular differentiation of the 
embryo from the one-cell state or zygote to an adult being. In order to study 
this process, ESCs derived from the epiblast of mammalian embryos can be 
used as an in vitro highly tractable model. ESCs possess two fundamental 
characteristics: self-renewal and pluripotency. Self-renewal is the capability of 
replication of a cell into the same cell state and pluripotency is the ability of a 
single cell to generate all the cell lineages.  In the case of mouse embryonic 
stem cells (mESCs), pluripotency can be captured in culture under different 
conditions (see methods 3.32 and 3.33) and each condition represents a 
different pluripotency state. Naïve pluripotency, which characterizes in vivo the 
epiblast cells of the mouse pre-implantational blastocyst, can be recapitulated 
in vitro by the addition of MEK and GSK3 inhibitors (i.e. 2i conditions) (Hackett 
and Surani 2014). Formative pluripotency represents a more advance stage 
distinctive of the post-implantaton epiblast, represented in vitro by epiblast-like 
cells (EpiLC) (Hayashi et al. 2011). Finally, as development proceeds and 
gastrulation starts, the epiblast cells aquire a primed pluripotent state in which 
somatic lineage specifiers start to be expressed and that is recapitulated in 
vitro by epiblast stem cells (EpiSC) (Smith 2017; Kalkan and Smith 2014).	  	  
Stem cell fate is determined by the equilibrium between self-renewal and 
differentiation signals. ESCs are able to respond to the signaling environment 
and either maintain the core pluripotency program or to exit the pluripotent 
state when differentiation signals appear. To initiate differentiation, ESCs have 
to escape from self-renewal, the transcriptional networks providing stem cell 
identity need to be extinguised and dififferentiation towards a specific lineage 
has to be specified. ESC differentiation involves the silencing of Nanog, 
Pou5F1 and other major pluripotency regulators. Moreover, lineage specific 
transcription factors (TFs) need to be induced in order to initiate the expression 
of a specific differentiation program (Young 2011). Ultimately, all these 
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processes are controlled at the chromatin level where transcriptional regulation 
is mediated by cis-regulatory elements like enhancers, promoters, silencers 
and insulators (Calo and Wysocka 2013; Signolet and Hendrich 2015). 
Enhancers in particular, play a key role during the exit of pluripotency and 
subsequent differentiation by controlling the specific set of genes that any 
given cell type expresses (de Laat and Duboule 2013). 
  
Lastly, during the exit of pluripotency, Polycomb group proteins (PcG) play also 
an important role. These proteins can act as transcriptional activators in certain 
cellular and genomic contexts as well as mediators of both short and long-
range genomic interactions that contribute to global genome architecture 
(Bantignies et al. 2011; Creppe et al. 2014; Denholtz et al. 2013; Entrevan et 
al. 2016; Joshi et al. 2015; Kondo et al. 2014; Kondo et al. 2016; Lanzuolo et 
al. 2007; Morey et al. 2015; Schoenfelder et al. 2015).  
 
This work is focused on the role of a unique group of enhancers, called poised 
enhancers as well as the function of PRC2 during mESCs differentiation. 
 
1.2- Enhancers regulate cell type transitions 
Enhancers are cis-regulatory elements that positively control gene expression 
over long distances and in an orientation independent manner (Spitz and 
Furlong 2012).  They are compact DNA sequences (200-500 bp) that act as a 
binding platforms for TFs (Figure 1.1) and play an important role in driving cell-
type specific gene expression (Bulger and Groudine 2011; Yáñez-Cuna et al. 
2013). TFs can bind to enhancers in a combinatorial and modular manner, 
allowing the establishment of different spatiotemporal gene expression 
programs (Figure 1.1) (Spitz and Furlong 2012). The importance of enhancers 
during embryogenesis is well illustrated in several studies where deletions of 
specific enhancers in animal models cause developmental abnormalities and 
affects gene expression patterns (Sagai et al. 2005).  
Introduction 
	   12	  
Enhancer 1
TFTF
Target gene
H3K4me1 H3K4me1
H3K27acH3K27ac
Enhancer 2
Target gene 
expression pattern
Insulators/
 TAD borders
Architectural proteins
Silencer
Activator
Positive regulation
Negative regulation
Tissue specific TF
Signaling effector TF
TF TF
Enhancer
	  
Figure 1.1: Genetic and epigenetic features of enhancers. Enhancers are able to 
confer cell type and developmental-stage specific spatiotemporal gene expression 
patterns by serving as integrating platforms of different types of developmental 
information (tissue-specific and signaling-dependent TFs, epigenetic modifications, 
recruitment of co-activators and architectural proteins). The regulatory influence of 
enhancers on the expression of nearby genes is delimited by insultators. (Adapted 
from Noonan, 2009). 
 
 
1.2.1- Identification and characterization of enhancers  
 
Despite their relevance, enhancers were difficult to identify due to the fact that 
they can drive transcription in a distance and orientation independent manner 
with respect to their putative genes, they do not present a stereotypic 
sequence composition and, in addition, they are not placed at a fixed position 
or distance with respect to their target gene promoters. However, this 
dramatically changed with the emergence of epigenomic approaches that 
based on the presence of particular chromatin signatures, allowed the global 
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identification of enhancers in a sequence conservation and cell type 
independent manner. Recent advances in genomic techniques like chromatin 
immunoprecipitation coupled to sequencing (ChIP-seq), (see methods 3.5.1) 
have enabled the global mapping of TFs and histone modification binding 
profiles. Importantly, enhancers can be identified using a variety of chromatin 
features, including the presence of certain histone marks, binding of 
transcription factors or chromatin accessibility (Figure 1.1) (Boroviak et al. 
2015; Kalkan and Smith 2014; Ying et al. 2008; Buenrostro et al. 2015; Menno 
P. Creyghton et al. 2010; Heintzman et al. 2009; Rada-Iglesias et al. 2011). 
 
Classically, the target genes of enhancers have been inferred based on 
correlative observations like proximity. However, enhancers can control the 
expression of genes located at great distances, which tipically involves the 
physical proximity between enhancers and their target genes (Calo and 
Wysocka 2013). Therefore, enhancers do not necessarily control the 
expression of their nearest genes. Chromatin Conformation Capture (3C) 
technologies and their derivatives allow evaluating the physical interaction 
between different genomic loci (de Wit and de Laat 2012; Duan et al. 2012; 
Simonis, Kooren, and de Laat 2007; Splinter et al. 2012; van de Werken et al. 
2012). For example, by using Circular Chromatin Conformation Capture 
coupled to sequencing (4C-seq), the genes that physically interact with the 
enhancers of interest and that are likely to represent their target genes can be 
identified (Figure 1.2). 
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Figure 1.2: 4C-seq methodology (adapted from Stadhouders et al. 2013). Cells are 
crosslinked in order to fix the interactions between DNA and proteins. After nuclei 
isolation, chromatin is digested and then ligated in order to evaluate the contacts of 
DNA fragments that are in proximity. Following reverse crosslinking, a second round 
of digestion-ligation is performed. Finally chimeric circular DNA molecules are 
obtained representing the contacts between different loci which can be amplified by 
inverse PCR using primers located within a locus of interest (bait or viewpoint) and 
subsequently sequenced (see methods 3.7). 
 
Enhancers were originally characterized using transient reporter gene assays 
in cultured cell lines, in which enhancer activity is tested in an exogenous and 
artificial genomic context (Banerji, Rusconi, and Schaffner 1981; Bulger and 
Groudine 2011). Since then, new methodologies, such as CRISPR-Cas9, have 
arised to characterize and determine the function of enhancers within their 
endogenous genetic and chromatin context. Briefly, this technique consists of 
gRNA molecules that guide the Cas9 nuclease to specific loci to introduce 
double-stranded DNA breaks at the desired location. Consequently, these DNA 
breaks can be repaired by non-homologous end-joining repair (NHEJ), which 
can result in the deletion of the sequence of interest (e.g. enhancer), whose 
function can then be evaluated. 
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1.2.2- Enhancer states 
 
These epigenomic methods also revealed that enhancers can exist in various 
regulatory states (e.g. active, primed, poised), which can be distinguished 
based on unique chromatin signatures and that display distinct regulatory 
properties (Table 1.1) (Calo and Wysocka 2013; Menno P. Creyghton et al. 
2010; Rada-Iglesias et al. 2011; Zentner et al. 2011). 
 
Active enhancers present low nucleosomal density, are bound by TFs and co-
activators (e.g. p300/CBP, CHD7, BRG1), are flanked by nucleosomes marked 
with histone three lysine four monomethylation (H3K4me1) and histone three 
lysine 27 acetylation (H3K27ac) and they are associated with highly expressed 
genes (Menno P. Creyghton et al. 2010; Rada-Iglesias et al. 2011; Zentner et 
al. 2011). 
 
Primed enhancers are marked with H3K4me1 but not H3K27ac. They are 
linked to genes that exhibit moderate expression levels and are implicated in a 
broad range of biological processes (Menno P. Creyghton et al. 2010; Zentner, 
et al. 2011).  
 
Poised enhancers (PEs) were defined originally in human and mouse 
embryonic stem cells (hESC, mESC) as a small group of highly conserved 
regulatory elements. Like active enhancers, they are also bound by TFs and 
co-activators (p300/CBP, CHD7, BRG1) and display low nucleosomal density. 
However, in contrast to active enhancers, they are not marked with H3K27ac 
but with histone three lysine 27 trimethylation (H3K27me3) instead, a 
repressive histone modification mediated by Polycomb Repressive Complex 
two (PRC2) (Rada-Iglesias et al. 2011; Zentner et al. 2011). Importantly, PEs 
are in proximity of genes with major cellular identity and developmental 
functions that are inactive in ESC and become expressed upon somatic 
differentiation. Since PEs are already bound in ESC by co-activators like P300, 
it has been proposed that they represent developmental enhancers that are 
bookmarked for their future activation once the appropriate differentiation 
signals are received (Rada-Iglesias et al. 2011; Spitz and Furlong 2012). 
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Additionally, it has also been proposed that the presence of H3K27me3 and 
PRC2 might keep PEs in an inactive state, preventing their spurious activation 
until the relevant differentiation cues become available (Tie et al. 2016).  
 
Table 1.1: Types of enhancers and their epigenetic features 
 
 
1.2.3- Mechanism of action of enhancers  
Since the discovery of enhancers, the dominant model to explain their 
mechanism of action involves the physical interaction of enhancers with their 
target promoters through the formation of chromatin loops. This “looping 
model” (Bulger and Groudine 2011; Calo and Wysocka 2013; de Laat and 
Duboule 2013; Vernimmen and Bickmore 2015) has received extensive 
experimental support from chromosome conformation capture  related 
technologies (e.g. 4C-seq, Hi-C, ChIA-PET) that enable the detection of 
physical interactions between distally located loci. Interestingly, most 
enhancer-promoter interactions occur within Topologically Associated Domains 
(TADs), which represent self-interacting Mb-scale domains that physically 
restrain enhancer activity to genes located within the same TAD (Figure 1.3) 
(Dixon et al. 2012). Although enhancer-promoter communication was originally 
proposed to occur once the target genes become active (Vernimmen et al. 
Properties Active 
enhancers 
Primed 
enhancers 
Poised 
enhancers 
DNAse I 
sensitivity 
Yes Not reported Yes 
H3K4me1 Yes Yes Yes 
H3K27ac Yes No In differentiated 
cells 
H3K27me3 No No In ESC 
Activator TFs Yes No Yes 
Associated 
genes 
High expressed 
genes 
Non specific Developmental 
regulators 
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2007), recent observations indicate that enhancer-promoter contacts can 
precede gene activation (Ghavi-Helm et al. 2014; Jin et al. 2013). At least in 
some cases, these pre-formed contacts might confer a permissive chromatin 
topology that poises genes for future induction (de Laat and Duboule 2013).  
In
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Figure 1.3: Chromatin landscape and mechanism of action of enhancers. The 
three-dimensional nuclear configuration of mammalian genomes is organized in 
topological associated domains (TADs). A TAD represents a region of DNA where 
physical interactions occur relatively frequently, whereas interactions across a TAD 
boundary occur relatively infrequently. Enhancer-promoter interactions occur within 
the same TAD, and they are facilitated by the numerous TFs, activators and 
architectural proteins that are associated to these regions. Figure adapted from (Dixon 
et al. 2012).   
 
The activation of gene promoters requires that many transcriptional 
components come together to assemble the pre-initiation complex (PIC), 
initiate transcription, overcome the paused RNA polymerase II (PolII) and 
eventually drive transcriptional elongation. By forming loops, enhancers come 
in close proximity with their target promoters and facilitate the aforementioned 
process by increasing the concentration of TFs and co-activators around the 
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promoter regions. Some of these factors include architectural proteins such as 
cohesin as well as mediator complexes and other factors (e.g. P300, BRD4) 
involved in releasing paused PolII and initiation of transcriptional elongation 
(Heinz et al. 2015) (Figure 1.3).  Interestingly, previous studies have 
demonstrated that removal of the promoter does not affect the recruitment of 
the PolII to the enhancer region, while the enhancer deletion does affect the 
binding of PolII to the promoter (Vernimmen et al. 2007). It is worth mention 
that enhancers are also transcribed (enhancer RNAs or eRNAs), although at 
low levels, and their expression correlates positively with the mRNA levels at 
their target genes (Vernimmen and Bickmore 2015). 
It has been described that PEs already communicate with their putative target 
genes in undifferentiated ESC (Schoenfelder et al. 2015). However, the 
molecular basis and functional relevance of these preformed PE-promoter 
contacts is currently unknown. Similarly, it is not clear yet if and how PEs 
control the expression of their target genes once activated.  
1.2.4- Poised enhancers during pluripotency and differentiation 
Previous reports (M. P. Creyghton et al. 2010; Rada-Iglesias et al. 2011) have 
determined that poised enhancers are developmental regulatory elements that 
are found in a silent but primed state in undifferentiated ESC. As mentioned 
above, one major distinctive feature of PEs is that they are bound by PRC2 
and, hence, marked with H3K27me3. Upon ESC differentiation, PEs get 
activated, lose H3K27me3 and gain H3K27ac (Rada-Iglesias et al. 2011; 
Zentner et al. 2011). These two histone modifications are mutually exclusive, 
implying that, despite being bound by co-activators with histone acetyl-
transferase (HAT) activity (e.g. P300, CBP) (Rada-Iglesias et al. 2011), the 
presence of H3K27me3 at PEs might avoid the accumulation of H3K27ac and 
the spurious activation of these regulatory elements (Pasini et al. 2010; 
Reynolds et al. 2012; Tie et al. 2016). Interestingly, this data is in concordance 
with the classically view of Polycomb group proteins as major epigenetic 
repressors playing important roles in differentiation and maintenance of cellular 
identity (Di Croce and Helin 2013). Additionally, some studies reported that 
PEs were also found in non-pluripotent cells and therefore, their relevance was 
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questioned since they were proposed to display a repressed rather than poised 
state or to even act as silencers (Bonn et al. 2012; Entrevan et al. 2016; Kondo 
et al. 2016; Spitz and Furlong 2012). However, in these and other studies the 
identification of PEs in ESC was based on the presence of H3K4me1 and/or 
H3K27me3 but the binding of TFs/co-activators was not required (Bonn et al. 
2012; Menno P. Creyghton et al. 2010; Schoenfelder et al. 2015).  
Due to the association of PEs with major cell identity and developmental 
regulators, it has been previously suggested that PEs might play important 
roles during the execution of somatic differentiation programs (Heintzman et al. 
2009; Bulger and Groudine 2011; Rada-Iglesias et al. 2012). However, we still 
do not know which mechanisms lead to lineage-specific activation of poised 
enhancers. Most importantly, the functional relevance of PEs is only supported 
by correlative observations, including reporter assays in zebrafish embryos that 
demonstrated that human poised enhancers sequences can act as 
developmental enhancers in vivo (Rada-Iglesias et al. 2011).  
 
In conclusion, the importance of PEs for the induction of their cognate genes 
and the execution of somatic differentiation programs has not been formally 
demonstrated. Correspondingly, it is also unknown if and how the PEs 
chromatin features actually facilitate the future activation of the PE target 
genes. (Rada-Iglesias et al. 2011; Zentner et al. 2011). Therefore, additional 
research is needed in order to elucidate these important questions. 
 
1.3- Polycomb group proteins 
 
Polycomb group proteins (PcG) are a large, conserved and diverse family of 
epigenetic regulators of transcription. Historically they have been considered 
as repressors of homeotic (HOX) genes, but more recently it has been 
revealed that they have broader roles in stem-cell identity, differentiation and 
disease (Chittock et al. 2017; Di Croce and Helin 2013; Pasini et al. 2010; 
Schoenfelder et al. 2015).  
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PcG proteins are part of transcriptional-repressive complexes, termed 
Polycomb Repressive Complexes (PRCs). Two major PRCs have been 
identified in most metazoan species, PRC1 and PRC2. In mammals, the 
canonical PRC1 contains two core subunits, RING1 which monoubiquitinates 
histone H2A on lysine 119 (H2AK119ub) and PcG ring finger protein (PCGF), 
which interacts with specific binding partners. PRC1 also contains a 
chromobox protein (CBX) which binds the H3K27me3 mark and a 
Polyhomeotic (PH) homolog protein (PHC). PHC proteins might play an 
important role in higher order chromatin organization by forming long-range 
contacts between remote PRC-bound sites in the genome (Figure 1.4) 
(Chittock et al. 2017; Di Croce and Helin 2013; Entrevan et al.2016). 
Canonical PRC1                    PRC2
RING1
CBX
PCGF
PHC
SUZ12
EED
EZH1/2 RbAp48
- Ubiquitination of H2AK119
- Binding to H3K27me3
- Chromatin compactation
- Blocking RNA PolII elongation
- Chromatin compactation
- Methylation of H3K27
JARID2
 
Figure 1.4: Composition of Polycomb group proteins. PcG consist of two main 
complexes, PRC1 and PRC2. PRC1 contains RING1, PHC, CBX and PCGF subunits 
(light-blue) and is responsible of ubiquitinilation of H2AK119, recognition of 
H3K27me3, chromating compactation and PolII inhibition. PRC2 consist of Suz12, 
EED and EZH the core subunit responsible of the methylation of H3K27. In addition, 
PRC2 also contains RbAP48, a protein which stabilizes the whole complex and 
Jarid2, a cofactor that facilitates the recruitment of PRC2 to its genomic targets 
(Entrevan et al. 2016; Blackledge, Rose, and Klose 2015; Di Croce and Helin 2013; 
Sanulli et al. 2015; Chittock et al. 2017). 
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The PRC2 core complex has three main proteins: EZH1/2, EED and SUZ12 
The SET (enhancer of zeste) domain-containing proteins responsible of 
methylation of H3K27, EZH1 and EZH2, are mutually exclusive and 
differentially expressed in proliferating and non dividing tissues (Entrevan et al. 
2016). EED (Embryonic ectoderm development) binds to H3K27me3 and 
contributes to the propagation of this repressive mark. SUZ12 (suppressor of 
zeste) is also required for the histone methyltransferase catalytic activity of the 
PRC2 complex. In addition, PRC2 also contains other subunits such as 
RbAp48, which stabilizes the complex, and JARID2, a co-factor which recruits 
PRC2 to its genomic targets (Figure 1.4) (Chittock et al. 2017; Di Croce and 
Helin 2013; Entrevan et al. 2016; Peng et al. 2009).  
 
1.3.1- Role of PcG in gene regulation 
 
Polycomb proteins are present at repressed genes with developmental 
functions. PcG repressive function entails chromatin compaction, mediated by 
PRC1, block of HATs (Histone Acetyltransferases) and interference with RNA 
Polymerase two (PolII) activity. PRC1 chromatin compaction activity involves 
the ligase activity of RING1 (Bantignies et al. 2011; Francis 2004) as well as 
the function of other PRC1 canonical subunits (e.g. CBX, PH) which can lead 
to the formation of subnuclear compartments, known as Polycomb bodies 
(Creppe et al. 2014; Schoenfelder et al. 2015, 1; Isono et al. 2005).  
 
On the other hand, PcG binding at gene promoters can interfere with 
transcription by “holding” PolII at the transcription start sites (TSS). This results 
in a “paused” PolII, unable to elongate. In agreement with this function, the 
deletion of RING1 results in PolII phosphorylation at serine2 (S2) and 
increased transcriptional elongation (Stock et al. 2007) Moreover, this PolII 
pausing function of PcG complexes might also explain the existence of so 
called bivalent promoters, which are enriched in H3K27me3 and histone three 
lysine four (H3K4me3). These bivalent promoters are typical of developmental 
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genes and particularly abundant in ESC where they are proposed to bookmark 
genes for subsequent activation upon differentiation. 
 
1.3.2- PcG in pluripotency and differentiation 
 
PcG proteins are essential for embryonic development and, mice lacking 
EZH2, EED or SUZ12 die soon after implantation (Faust et al. 1998; O’Carroll 
et al. 2001; Pasini et al. 2004). On the other hand, PRC2 activity is not required 
for mESCs self renewal although it appears necessary for proper 
differentiation. Nevertheless, EED-/- mESCs, which display very low PRC2 
activity and H3K27me3 levels, are able to contribute to all embryonic tissues 
when injected into mouse blastocyst, indicating that PRC2 null mESCs are to 
some extent pluripotent (Chamberlain et al. 2008).  
 
On the contrary, the role of PRC1 in ESC self-renewal and differentiation is not 
as clear due to the large variety of PRC1 complexes and associated subunits. 
It has been reported that, with the exception of RING1B, the deletion of most 
PRC1 subunits leads to late developmental defects during mouse 
embryogenesis. However, embryos with deletion of at least two PRC1 subunits 
(two different ring finger subunits (Akasaka et al. 2001) or ZFP144 ring finger 
protein and RING1B (Isono et al. 2005)) failed to pass midgestation. 	  
Taken together, the data suggest that in vitro, PcG proteins are not required for 
mESC self renewal but can affect pluripotency and differentiation potential 
(Riising et al. 2014).  
 
1.3.3- Recruitment of PcG 
Previous studies reported that the recruitment of canonical PRC1 complexes 
depends on the presence of the H3K27me3 mark deposited by PRC2, which is 
recognized by the chromodomain of the CBX subunits (Min et al. 2003). On the 
other hand, other studies described that PRC1 complexes are targeted to CpG 
islands (CGIs) by the KDM2B histone demethylase. PRC1 then catalyzes H2A 
ubiquitination, which in turn can recruit PRC2 (Blackledge et al. 2014). 
Although PcG recruitment mechanisms are not fully understood, CGIs have 
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recently emerged as potential Polycomb response elements (PREs) in 
vertebrates, similar to those previously described in Drosophila (Entrevan et al. 
2016). Different mechanisms have been suggested for the recruitment of 
PRC2 to CGIs. JARID2, a PRC2 co-factor, has a DNA binding domain that 
preferentially binds to CpG-rich sequences and could thus help in the 
recruitment of PRC2 to CpG islands (CGIs). Accordingly, the loss of JARID2 
leads to a decrease in PRC2 binding to their target genes (Di Croce and Helin 
2013; Peng et al. 2009). More recently, non-canonical PRC1 complexes 
containing RYBP (RING1A and YY1 binding protein) and KDM2B were shown 
to bind to CGIs in the absence of H3K27me3 (van den Boom et al. 2016). For 
instance, the histone lysine demethylase KDM2B, has been reported to 
specifically recognize non-methylated DNA in CGIs and recruit PRC1 (Farcas 
et al. 2012). RYBP and its mouse homolog YAF2 are responsible for PcG 
recruitment to DNA, which is mediated by YY1 TF DNA binding (Basu et al. 
2014). 
 
Recent studies indicate that the transcriptional status at CGIs can determine 
whether PcG complexes are recruited to their target genes, since global 
inhibition of transcription lead to ectopic recruitment of PcG proteins to all CGIs 
(Riising et al. 2014). In addition to CGI, sequence-specific TFs like SNAIL, 
REST or PLFZ can regulate the recruitment of PRC2 to their target genes 
although this does not seem to be a general mechanism for PcG recruitment, 
and TFs may only transiently associate with PcG (Dietrich et al. 2012). Lastly, 
several studies propose that noncoding RNAs have a role in gene silencing 
and PcG-protein recruitment. RNA-immunoprecipitation techniques have 
identified several thousand of RNAs associated with PRC2 and furthermore, it 
has been demonstrated that the long noncoding Xist transcript can interact with 
PRC2 during the inactivation of the X chromosome (Plath et al. 2003). 
However, most recently, RNA binding to PcG proteins has been suggested to 
facilitate the eviction rather than the recruitment of these complexes to their 
chromatin targets (Aranda et al. 2015). 
 
In summary, different models of recruitment of PcG proteins have been 
proposed, although most likely several of the suggested mechanisms might act 
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in a combinatorial manner to confer robustness to the binding of these 
important epigenetic repressors to their cognate genomic targets. 
 
1.3.4- PcG as major organizers of nuclear architecture 	  
It is known that cell fate transitions are accompanied by alterations in 
chromatin structure. The action of PcG on chromatin leads not only to 
compaction, but also to specific 3D chromatin folding (Bantignies et al. 2011). 
Due to the appearance of novel approaches to study genome nuclear 
organization, such as 3C and derivative techniques (e.g. 4C-seq, Hi-C), it is 
now possible to elucidate the topological organization of chromatin within the 
nucleus.  	  
PcG are starting to emerge as major organizers of nuclear architecture.  For 
example, it has been demonstrated that the repressive chromatin hubs found 
at the homeotic bithorax complex (BX-C) locus in Drosophila are composed of 
multiple chromatin loops. In these loops, all major interacting elements, 
including core promoters and PREs, are bound by PcG. As a result, a 
topologically complex structure referred to as a PcG body is formed and 
required for the silencing of BX-C (Lanzuolo et al. 2007). Furthermore, it has 
been also shown that switches in the BX-C transcriptional status are 
accompanied by major rearrangements in the high order chromatin structures 
(Lanzuolo et al. 2007). On the other hand, in mECSs it has been revealed that 
EED, one of the PRC2 subunits, is required for the maintenance of interactions 
between PcG regions separated by tens of megabases or even located on 
different chromosomes (Denholtz et al. 2013). These interactions were 
reduced when mESCs were grown under naïve pluripotency conditions, most 
likely due the lower genomic levels of PcG complexes and associated histone 
marks (e.g. H3K27me3) present under those conditions (Tee et al. 2014). 
Similarly, it has been recently reported that RING1 depletion in mESC leads to 
the lost of long-range interactions between PcG target genes, while 
interactions between active pluripotency genes remained unaffected 
(Schoenfelder et al. 2015). Moreover, PcG-bound promoters also interacted 
with poised enhancers marked by H3K4me1 and H3K27me3. Remarkably, 
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loss of RING1 led to activation of poised enhancers, whereas poised 
enhancer–promoter contacts were overall maintained. Lastly, it has been also 
proposed that during mouse brain development, the Meis2 gene promoter is 
initially associated with a silencing element via RING1B. Interestingly, this 
PcG-bound element topologicaly facilitates the subsequent interaction between 
Meis2 and a specific enhancer, ultimately leading to gene activation. When 
RING1B is not present, the enhancer can no longer contact the promoter 
region, resulting in reduced Meis2 expression (Kondo et al. 2014).  
 
Since TADs were discovered, research efforts have been invested in 
understanding the link between chromatin 3D structure and gene expression. 
In Drosophila, TADs can be broadly classified into active, inactive and PcG-
repressed states. PcG TADs are the most compact, show the highest inter-
TAD interactions and display minimal contacts with other domains. On the 
other hand, active and transcriptionally inactive TADs show higher levels of 
inter-domain mixing. It has been illustrated that PH, a component of Polycomb 
PRC1, plays an important role in these interactions and without PH, PcG TADs 
are lost (Boettiger et al. 2016). In agrrement with this study, it was shown that 
the disruption of the polymerization activity of the PH sterile alpha motif (SAM) 
domain leads to a dispersion of PcG clusters and chromatin interactions. 
Moreover, similar findings were recently reported in mouse cells (Isono et al. 
2013). Overall, these recent reports indicate that PH SAM domains may 
mediate the organization of PcG proteins into Polycomb bodies (Figure 1.5) 
(Wani et al. 2016). 
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Figure 1.5: Proposed model for Polyhomeotic (PH) SAM domains in the 
formation of Polycomb bodies. PcG complexes are recruited to their target sites via 
PREs and PcG polymerization occurs through SAM-mediated interactions. PcG-
mediated looping might involve the recognition of H3K27me3 (dark blue lollipop) by 
PRC1 and the PRC1 polymerization mediated by PH SAM domains. These 
PRC1/PRC2 clusters correspond to microscopically visible subnuclear domains 
known as Polycomb bodies. These Polycomb bodies or Polycomb domains (yellow 
circle) are significantly more compacted than transcriptionally inactive (purple) or 
active (pink) domains. Adapted from (Entrevan et al. 2016).  
 
The role of PRC2 in regulating global nuclear architecture is still not very clear. 
As it was mentioned previously, the loss of EED in mESCs leads to reduced 
interactions between Polycomb-bound regions (Denholtz et al. 2013; Joshi et 
al. 2015). However, it was also reported that the loss of PRC2 did not affect 
TAD boundaries either globally or across the X chromosome (Nora et al. 
2012). Nevertheless, it has been demonstrated that induced recruitment of 
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EZH2 to a particular locus can lead to relocation into a new nuclear 
compartment occupied by other Polycomb-bound regions. This study suggests 
that specific nuclear subcompartments, including PcG domains, are formed as 
a consequence of affinities between chromatin-associated proteins or 
modifications (Wijchers et al. 2016). 
 
In summary, PcG proteins can mediate looping interactions between regulatory 
elements, define global nuclear architecture and ultimately regulate gene 
expression. However, the role of PcG upon PEs activation and lineage 
commitment needs to be further characterized. 
 
 
Aim 
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2- AIM 
 
The knowledge about the establishment of gene expression programs during 
mammalian developmental transitions is far from being completed. We 
hypothesize that poised enhancers are important regulatory elements that, in 
ESCs, display a silent but primed state sustained by PcG. Moreover, we also 
hypothesize that, once activated, poised enhancers might be important for the 
induction of their target genes during the earliest steps of somatic 
differentiation. Therefore, the major goals of this project are to examine the 
functional and developmental relevance of poised enhancers and to 
investigate how PcG influences poised enhancer’s regulatory activity.  
 
In order to fulfill these objectives, we first characterized poised enhancer 
candidates with well-defined activation dynamics during mESCs differentiation 
into anterior neural progenitors. Secondly, we identifed the putative target 
genes of poised enhancers based on their physical interactions. Then, we 
engineered poised enhancer deletions to assess the functional importance of 
these regulatory elements during mESCs differentiation. Lastly, we examined 
the role of PcG, specially the PRC2 complex as a regulator of poised 
enhancers activity and function. 
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3. MATERIAL AND METHODS 
3.1 – Equipment 
Table 3.1: Equipment 
Equipment Company Catalog number 
Bacteria Incubator Infors HT Ecotron s00120638 
Cell culture Incubator Sanyo 8070263 
Microscopes 
  Inverted microscope Leica DMILED 376977 
Fluorescent microscope Olympus IX2-UCB 9A01123 
Microscope ECLIPSE TS100 Nikon Kurian’s Lab 
Electrophoresis  
  Chambers Biorad 1704502 and 1704406 
Power supply Biorad 041BR110323 
Western Blot 
  Chamber Biorad 1658004 
Power supply Biorad 043BR500041 
Centrifuges 
  Cell culture Hermle 311001101 
Big 4° for falcon tubes Hermle 31130026 
Small 4° for eppendorf tubes Hermle 61150064 
For bacterial liquid culture Labscience 7.601.314.101 
Cell culture bath Memmert 325741 
Tissue Culture hood Kojair 22198 
Bioruptor plus Diagenode Brng130125 
PRC Thermal cycler 
  q-PCR LightCycler 480 II Roche 5662 
c1000 Touch Biorad ct024292 
Electic balance Kern WB1251009 
Regular balance Kern WB1300143 
Spectrophotometer Nanodrop Thermo Scientific F673 
pH meter Sartorius 29053099 
Automated cell counter Biorad 508BR05586 
Shaker Skyline 12DE117 
Thermo Block Ditabis 980052301 
ChemiDoc MP Biorad 731br01726 
 
 
 
Materials and Methods 
	   30	  
3.2- Chemicals and reagents 
3.2.1- Chemicals 
Table 3.2: Chemicals 
Reagent Company Catalog number 
2-Propanol Roth 9866.5 
25:24:1 Phenol- Chlorophorm Isoamyl 
Alcohol Sigma Aldrich P2069 
4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid 
(HEPES) Roth HN78.2 
30% Acrylamide/ Bis solution Sigma Aldrich 161-0156 
Adenosine triphosphate (ATP) Sigma Aldrich A2383 
Agarose Life Technologies 16500100 
Bovine Serum Albumina (BSA) Roth, Germany 3737.2 
Bromophenol Blue Sigma Aldrich B0126 
Chloroform Sigma Aldrich 366919 
DAPI Sigma Aldrich D9542-5MG 
Dithiothreitol (DTT) Roth 6908.3 
Ethanol Roth 5054.3 
ethylendiaminetetraacetic acid (EDTA) Roth 8043.1 
ethylene glycol-bis(β-aminoethyl 
ether)-N,N,N',N'-tetraacetic acid) EGTA Roth 3054.2 
Formaldehide solution 37% Sigma Aldrich 252549 
Glycerin Sigma Aldrich 68898 
Gycerol Roth 3783.2 
Hydrochloric acid (HCl) Roth 281.1 
Litium Chloride (LiCl) Roth 3739.2 
Magnesium Chloride (MgCl2) Roth KK36.2 
Methanol Sigma Aldrich 494437 
Mounting medium Southern Biotech 0100-01 
N-Lauroylsarcosine Sigma Aldrich 61743 
Na-Deoxycholate Sigma Aldrich D678 
Non-Fat Milk Hartestein CM35 
NP-40 Sigma Aldrich I3021 
Parafolmaldehide Sigma Aldrich 158127 
Phosphate buffered saline (PBS) Sigma Aldrich D8537 
Potasium Chloride (KCl) Roth HN02.3 
Sodium Acetate (C2H3NaO2) Roth 6773.2 
Sodium Chloride (NaCl) Roth 3957.2 
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Sodium dodecyl sulfate (SDS) Roth 183.3 
Triton X-100 Roth 3051.4 
Trizma Base Sigma Aldrich T1503  
Trizol (Tripure) Roche 11667157001 
Tween-20 Roth 9127.2 
 
3.2.2- Buffers and solutions 
Table 3.3: Buffers 
Buffer/ Solution Composition 
Blocking Solution ChIP PBS  (1x)  
0.5% BSA (w/v) 
Lysis Buffer 1 (LB1) 50 mM Hepes (pH 7,5) 
140 mM NaCl 
1 mM EDTA 
10% glycerol 
0.5% NP-40 
0.25% TX-100 
dH20 
Lysis Buffer 2 (LB2) 10 mM Tris pH 8 
200 mM NaCl 
1 mM EDTA 
0.5 mM EGTA 
dH20 
Lysis Buffer 3 (LB3) 10 mM Tris pH 8 
100 mM NaCl 
1 mM EDTA 
0.5 mM EGTA 
0.1% Na-Deoxycholate 
0.5% N-lauroylsarcosine 
dH20 
RIPA Wash Buffer for ChIP 50 mM HepespH 7,5 
500 mM LiCl 
1 mM EDTA 
1% NP-40 
0.7% Na-Deoxycholate 
dH2O 
Elution Buffer 50 mM Tris pH 8 
10 mM EDTA 
1% SDS 
dH2O 
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Dilution Buffer (Sequential ChIP) 20 mMTris-HCl pH 8 
2 mMEDTA 
1% Triton X-100  
150 mM NaCl 
dH2O 
RIPA Wash Buffer for Western Blot 50 mM Tris, pH 8.0 
150 mM NaCl 
1.0 % NP-40 
0.5% sodium deoxycholate 
0.1% SDS 
dH2O 
Laemmli buffer 375 mM Tris pH  6.8 
60% glycerol 
600 mM DTT 
0.06% bromphenol blue 
12% SDS 
dH2O 
Running buffer 25 mM Tris pH 8,3  
190 mM glycine 
 0.1% SDS 
dH2O 
Transfer buffer 25mM Tris 
190 mM glycine 
20% Methanol 
0.1 % SDS 
dH2O 
PBST washing buffer PBS 
1% Tween 
Blocking Solution for Western Blot 5% milk 
1% PBST 
Permeabilizing solution IF 0.3% Triton X-100  
dH2O 
Lysis Buffer for 4C 50 mM Tris–HCl pH 7.5 
150 mM NaCl 
5 mM EDTA 
0.5% NP-40 
1% TX-100 
1X protease inhibitors 
dH2O 
Ligation Buffer for 4C 50 mM Tris-HCl pH 7.6 
10 mM MgCl2 
1 mM ATP 
1mM DTT 
dH2O 
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TE Buffer 10 mM Tris  pH 8.0 
1 mM EDTA 
dH2O 
TAE buffer (1X) 40mM Tris pH 8.6 
20mM Acetate 
1mM EDTA 
dH2O 
3.2.3- Kits and commercial assays 
Table 3.4: Kits 
Kits Company Catalog number 
Innuprep RNA mini kit  Analytic Jena 845-KS-2040250 
ProtoScript II First Strand cDNA 
Synthesis Kit  NEB E6560L 
PCR purification column  QIAgen 28104 
SuperScript® VILO™ cDNA Synthesis 
Kit Thermo Fisher  11754-050 
Nucleospin Plasmid MiniPrep, 250 rxn Macherey-Nagel 740588-250 
3.2.4 – Cell culture reagents 
Table 3.5: Cell culture medium 
Medium Components Company Catalog 
number 
Serum +LIF 15% Fetal Bovine Serum 
(FBS)  
Life 
Technologies 
16141-061 
1 % Antimycotic/antibiotic  Hyclone SV30079.01 
0.02% Beta-
mercaptoethanol 55 mM  
Life 
Technologies 
21985-023 
1 %Glutamax  Life 
Technologies 
35050-038 
1 % MEM NEAA  Life 
Technologies 
11140-035 
Knock-out DMEM  Life 
Technologies 
10829-018 
LIF  N/A N/A 
Freezing medium 
Serum plus LIF 
(2x) 
40% Serum plus LIF 
medium 
  
40% FBS Life 
Technologies 
16141-061 
10% DMSO Sigma Aldrich D2650 
N2B27  50% DMEM/F-12 Invitrogen 21041-025 
0.5 % N2 suplement Invitrogen 17502-048 
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25 µg/m Insulin Sigma Aldrich I-1882 
1% penicillin-
streptomycin 
Invitrogen 15070 
2 mM  l-glutamine  Invitrogen 25030-081 
50% Neurobasal medium Invitrogen 12348-017 
1 % B27 suplement Invitrogen 12587-010 
0.1 mM  β-
mercaptoethanol  
Sigma Aldrich M6250 
2i medium N2B27 medium   
3 µM CHIR 99021 Amsbio 1677-5 
0.4 µM PD 325901 Miltenyi 
Biotech 
130-103-
923 
LIF Housemade  
0.3 % BSA  Invitrogen 15260-037 
Freezing medium 
2i (1x) 
50% N2B27   
40% FBS Invitrogen 16141-061 
10% DMSO Sigma Aldrich D2650 
Tryple Wash 
medium  
DMEM/F-12 Invitrogen 21041-025 
10 % BSA  Invitrogen 15260-037 
Mesodermal 
precursors basal 
medium 
75% IMDM  Thermo 
Scientific 
21980032 
25% Ham’s F12  Thermo 
Scientific 
11765054 
2mM GlutaMax  Life 
Technologies 
35050-038 
0.5X B27 supplement  Invitrogen 12587-010 
0.5X N2 supplement  Invitrogen 17502-048 
50 µg/ml Ascorbic acid Pan Biotech P04-0070K 
4.5x10-4 M 
Monothioglycerol 
Sigma Aldrich M6145 
0.05 % BSA                                                             Invitrogen 15260-037 
Mesodermal 
precursors 
differentiation 
medium 
Basal mesodermal 
medium 
  
5 ng/ml human VEGF Pan Biotech P04-0070K 
4 ng/ml  human Activin A  Peprotech 120-14-10 
0.2 ng/ml human BMP4 Miltenyi 
Biotech 
130-098-
786 
 
Table 3.6: Cell culture reagents  
Reagent Company Catalog number 
Trypsine Thermo Fisher 25200072 
Tryple Express Thermo Fisher 12604-021  
Xav939 Sigma Aldrich x3004 
Puromycin Thermo Fisher A2856,0025 
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Optimem medium for transfection Thermo Fisher 51985026 
X-tremeGene transfection reagent Roche 6366236001 
b-FGF Peprotech 100-18B 
Neomycin AppliChem A6798,0020  
 
3.2.5 – Molecular biology reagents 
Table 3.7: Molecular biology reagents 
Reagent Company Catalog number 
Proteinase K Sigma Aldrich P2308 
RNAse A Peqlab 12-RA-03 
Turbo DNAse Thermo Fischer AM1907M 
Proteinase Inhibitors Roche 5892953001 
Glycogen Peqlab 37-1810 
Lumi-Light Western Blotting 
Substrate 
Roche 1.2015196E 
QuickExtract DNA Extraction 
Solution  
Biozym QE09050 
TRIzol® Reagent /tripure Roche 11667157001 
dNTPS Promega U1515 
SYBR&reg; Safe DNA gel stain Invitrogen S33102 
Dynabeads Protein G Thermo Fisher 1004D 
Protease inhibitor cocktail Roche 05892953001 
  
GeneRuler 1 kb Plus DNA Ladder, 
75-20,000 bp 
Peqlab 25-2240 
Table 3.8: Enzymes 
Enzyme Company Catalog number 
NlaIII NEB R0125L 
DpnII NEB R0543M 
BsaI NEB R0539L 
T4-Ligase (1U/µl) Invitrogen 15224-041 
T4-Ligase NEB M0202M 
Expand long template PCR system  Roche 11681842001 
Platinum Taq polymerase  Life technologies 10966034 
ORA qPCR Green ROX L Mix HighQu QPD0105 
One Taq DNA polymerase NEB M0509S 
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3.2.6 – Bacterial culture reagents 
Table 3.9: Bacteria strains 
Bacteria strains Source Identifier 
CopyCutter EPI40 
Electrocompetent E. coli 
Epicentre 
Biotechnologies 
C400EL10 
Top10 E.Coli Kurian Lab N/A 
Table 3.10: Plasmids 
Plasmid  Source Identifier 
PB enhancer GFP Neo Buecker et al., 2014 N/A 
pX330-U6-Chimeric_BB-
CBh-hSpCas9 
Addgene 42230 
pX330-hCas9-long-
chimeric-grna-g2p 
Kurian Lab N/A 
Super PiggyBac 
Transposase 
System Biosciences PB210PA-1 
 
3.3 -Cell culture procedures 
Cell culture work was performed under sterile conditions in order to avoid 
contamination. Sterile conditions were guaranteed by laminar flow cell culture 
hoods as well as sterile solutions, materials and medium supplemented with 
antibiotics and antimycotics. Cells were kept in an incubator at 37° in a humid 
atmosphere containing five per cent CO2. 
3.3.1- Cell lines                                  
For this study, we used three different types of mESCs lines and we generated 
seven PE knockout lines: 
Table 3.11: mESC lines used in culture 
Cell line  Reference 
WT (E14) mESC Wysocka Lab 
EED-/- mESC Schoeftner et al., 2006 
SUZ12-/- mESC Pasini et al., 2007 
PE Lhx5 (-109)-/- N/A 
PE Six3 (-133)+/- N/A 
PE Six3 (-133)-/- N/A 
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PE Wnt8b (+21)+/- N/A 
PE Sox1 (+35)-/- N/A 
PE Sox21 (+3,5)-/- N/A 
 
3.3.2- Culture of mESCs in serum plus LIF conditions 
WT (E14) mESC, EED-/- mESC (Schoeftner et al. 2006) and mESC lines with 
PE deletions were grown on gelatin-coated plates using Knock-out DMEM 
(KO-DMEM, Life Technologies) supplemented with 15% FBS (Life 
Technologies) and LIF in order to promote a primed pluripotency state (Table 
3.5). 
3.3.3- Culture of mESCs in “2i” conditions 
For inducing the “naïve ground state of pluripotency” (see introduction 1.1), WT 
(E14) mESC were grown in 2i plus LIF medium, as it has been previously 
reported (Respuela et al. 2016). To reach this state, mESCs growing in serum 
plus LIF were disaggregated using Tryple Express and washed with Tryple 
wash medium (Table 3.5). Afterwards, cells were splitted 1:8-1:10 and cultured 
in N2B27 medium supplemented with MEK inhibitor PD0325901 at 0.4 µM, 
GSK3 inhibitor CHIR99021 at 3 µM, and LIF in cell culture dishes pre-treated 
with gelatin during at least four passages.  
3.3.4- Differentiation into Anterior Neural Progenitors (AntNPCs) 
E14 mESC were plated at a density of 10000 cells/cm2 on gelatin-coated 
plates and grown for three days in N2B27 medium supplemented with 10 ng/ml 
b-Fgf  (Table 3.5) without serum or LIF, following a previously described 
protocol (Gouti et al. 2014) with slight modifications. Subsequently, cells were 
grown for another two days in N2B27 medium without b-Fgf (D3–D5).  
Moreover, to improve the homogeneity of the differentiation, from D2-D5 the 
N2B27 medium was also supplemented with 5µM Xav939, a potent WNT 
inhibitor (see results 4.2) (Matsuda and Kondoh 2014). 
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3.3.5- Differentiation into mesodermal progenitors 
E14 mESCs were plated at 75.000 cells/ml in a mixture of 75% IMDM (and 
25% Ham’s F12, supplemented with GlutaMax, B27, N2, Ascorbic acid 4.5x10-
4 M, Monothioglycerol and BSA in order to produce embryonic bodies. After 
48h, embryonic bodies were dissociated and re-aggregated for two days in the 
presence of 5 ng/ml human VEGF, 4 ng/ml human Activin A and 0.2 ng/ml 
human BMP4 following the instructions of a reported protocol (Wamstad et al., 
2012).  
3.4- Molecular biology methods 
3.4.1- Genomic DNA isolation 
DNA was isolated using QuickExtract DNA Extraction Solution 1.0 (Table 3.7) 
or an already established isolation protocol. Briefly, in this protocol, cells were 
suspended at 107 cells /ml in 10 mM Tris (pH 8.0), 10 mM EDTA. Then SDS 
and Proteinase K were added to a final concentration of 0.5% and 200 µg/ml, 
respectively.  The mixture was incubated at 55 °C for 2 h. After that, NaCl was 
added to a final concentration of 0.2 M. The extraction was done twice with 
equal volumes of phenol/chloroform/isoamyl alcohol (25:24:1) and once with 
chloroform. RNase A was added to a final concentration of 25 µg/ml and 
incubated for 1 h at 37 °C. Another extraction with phenol/ chloroform/isoamyl 
alcohol (25:24:1) was done followed by a second one with only chloroform. 
DNA was precipitated with 1.5 volumes of ethanol followed by a centrifugation 
at 10000g for 5 minutes to pellet the DNA. The DNA pellet was washed with 
70% ethanol twice and centrifuged at 10000g for 5 minutes. Finally the DNA 
pellet was resuspended in water.  
 
3.4.2- RNA isolation 
Total RNA was isolated using innuprep RNA mini kit (Table 3.4) according to 
the manufacturer’s instructions or Tripure reagent (Table 3.7). For the Tripure 
isolation, this reactive was added directly to the wells after washing with PBS 
(500 µL reagent per 1x106 cells), following a two minutes incubation at RT. 
Afterwards, cells were resuspended, transferred to an eppendorf and a five 
minutes additional incubation at RT was performed to ensure complete 
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dissociation of nucleoprotein complexes.  Then, chloroform was added (100 µL 
per 500 µL Tripure), followed by vigorous mixing and a posterior RT incubation 
during 10 min. Samples were centrifuged subsequently at 12.000g for 15 
minutes at four degrees and the upper aqueous phase was isolated.  RNA was 
precipitated by adding isopropanol to the aqueous phase (250 µL isopropanol 
per 500 µL Tripure), followed by intensive mixing and posterior incubation at 
RT during 10 min. Subsequently, samples were centrifuged at 7500g for 5 min 
at four degrees and pellet representing RNA was resuspended in RNAse free 
water. RNA concentration was measured by using Qubit fluorometer. 
 
3.4.3- cDNA synthesis 
To perform expression analyses, RNA was reversely transcribed into cDNA 
since RNA cannot serve as a template for RT-qPCR, cDNA was generated 
using ProtoScript II First Strand cDNA Synthesis Kit (Table 3.4). Exclusive 
transcription of mRNAs was warranted using an oligo-dT Primer binding to the 
mRNA specific poly-A tail.  
3.5- Immunological methods 
3.5.1- ChIP (Chromatin Immunoprecipitation) 
A previously described protocol (Boyer et al. 2005) was followed with slight 
modifications. Briefly, 50 million of cells for a P300 ChIP or 10 million for 
histones ChIP were crosslinked with 1% formaldehyde for 10 minutes at RT 
and then quenched with 0,125M glycine for another 10 min. Posteriorly, cells 
were rinsed with PBS and resuspended sequentially in three different lysis 
buffers (Table 3.3) to isolate chromatin. Chromatin was then sonicated for 18 
cycles (30 sec on 45 sec off) for P300 ChIP and 23 cycles for histones ChIP 
using the Bioruptor Plus. After sonication the material was centrifuged during 
10 min at 16000g and 4°C. Afterwards, the chromatin from the supernatant 
was divided in different aliquots that were incubated overnight at 4 °C with 3 µg 
antibody for histones and 10 µg for P300 (Table 3.12). One of the aliquots was 
not incubated with the antibody, representing total input control for the ChIP 
reactions. Next day 100 µl of protein G magnetic beads were added to the 
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P300 ChIP reactions and 75µl to the histones ChIP. After four hours incubation 
at 4 °C, magnetic beads were washed with RIPA buffer and chromatin eluted, 
followed by reversal of the crosslinking and DNA purification. Briefly, for DNA 
purification, two extractions were performed, one with phenol/ 
chloroform/isoamyl alcohol (25:24:1), followed by a second chloroform 
extraction. The aqueous phase was isolated and DNA was precipitated during 
30 minutes at -80°C by adding 1/10 of the volume of Sodium acetate, 1 µl 
glycogen (as internal carrier) and 3 volumes of 100% Ethanol. Afterwards, 
samples were centrifuged during additional 30 minutes at 4°C with DNA 
representing pellet. DNA was eluted in water. All antibodies used have been 
previously reported as suitable for ChIP (see Table 3.12). ChIP samples were 
analyzed by q-PCR using the primers shown in Table 3.25.  
Table 3.12: Antibodies for ChIP 
Antibodies Company Reference 
P300 Santa Cruz sc-585 
H3K4me1 Active motif 39297 
H3K4me3 Active motif 39159 
H3K27me3 Active motif 39155 
H3K27ac Active motif 39133 
RNA Pol2 8WG16 Covance MMS-126R-500 
S5p RNA Pol2 Abcam ab5131 
 
3.5.2- Sequential ChIP 
A previously described protocol (Furlan-Magaril et al., 2009; Rada-Iglesias et 
al., 2011) was followed. Chromatin was prepared as described above for ChIP, 
after addition of the first antibody (H3K27me3, 3 µg) the corresponding washes 
were performed. Magnetic beads were then re-suspended in 75 ml TE/10 mM 
DTT solution. DNA samples were diluted 20 times with dilution buffer and 
second antibody (10 µg of P300 or GFP (Mock) antibodies) was added. Finally, 
beads were washed, crosslinking reversed, DNA purified and dissolved in 
water. 
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3.5.3- Western blot 
Proteins from WT (E14), PE Lhx5-/- (-109) mESC and their AntNPCs were 
extracted using RIPA buffer supplemented with protease inhibitor cocktail 
(Table 3.3). After 20 minutes of incubation on ice, protein extracts were 
recovered by centrifugation (20 minutes at 14000g). For western blot 30 µg of 
protein were mixed with Laemmli buffer, heated to 95º and then separated in a 
12% SDS-PAGE gel in running buffer (Table 3.3). Proteins were transferred to 
a PVDF (polyvinylidene difluoride) membrane using transfer buffer for 90 
minutes at 80V. The membranes were blocked for 1 h with blocking solution 
and incubated afterwards with primary antibody overnight at 4°C (Table 3.13). 
After 3 x 5 min washes with PBST washing buffer, the membranes were 
incubated with the secondary antibody for 1 h at room temperature (Table 
3.14). Horseradish peroxidase coupled anti-IgG antibody was detected using a 
chemiluminescence substrate.  Antibodies used are listed on the tables: 
 
Table 3.13: Primary Antibodies for western blot 
Antigen Host Dilution Company Reference 
LHX5 Goat 1:1000 R&D Systems AF6290 
TUBULIN Mouse 1:10000 Millipore MAB3408 
ZIC2 Rabbit 1:1000 Abcam ab150404 
 
Table 3.14: Secondary Antibodies for western blot 
Species Conjugated Dilution Company Reference 
Anti-mouse HRP 1:10000 Invitrogen 616520 
Anti-goat HRP 1:10000 Invitrogen 611620 
Anti-rabbit HRP 1:5000 Invitrogen 656120 
 
 
3.5.4- Immunofluorescence staining 
mESCs and AntNPCs growing in 12 well plates were rinsed with PBS and then 
fixed for 12 min in 4% paraformaldehyde (PFA) in PBS at room temperature 
(RT). PFA was removed and cells were rinsed with PBS. Cells were 
permeabilized during seven minutes at RT, followed by incubation with 
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blocking solution for 30 min at RT (Table 3.3).  Incubation with primary 
antibodies was done in blocking solution overnight (12–18 h) at 4 °C with 
gently shaking (Table 3.15). Cells were rinsed three times with PBS and 
incubated with secondary antibodies in blocking solution for one hour at room 
temperature and then rinsed again with PBS (Table 3.16). Finally, cell nuclei 
were stained with DAPI (1µg/ml) during 10 min at RT and then mounted with 
anti-fading mounting medium. 
 
Table 3.15:  Primary Antibodies for immunofluorescence 
Antigen Host Dilution Company Reference 
POU5F1 Goat 1:500 Santa Cruz 
Biotecnhology 
sc-8628 
NESTIN Rabbit 1:500 Covance PRB-315C 
PAX6 Mouse 1:100 Hybridoma 
Bank 
PAX6 
LHX5 Mouse 1:500 Santa Cruz 
Biotecnhology 
sc-130469 
 
Table 3.16: Secondary Antibodies for immunofluorescence 
Species Conjugated Dilution Company Reference 
Anti-mouse 488 1:500 Life 
Technologies 
A11001 
Anti-goat 594 1:500 Life 
Technologies 
A11058 
Anti-rabbit 488 1:500 Life 
Technologies 
A11008 
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3.6 - Genetic deletions using clustered regulatory interspaced 
short palindromic repeats (CRISPR-Cas9) 
3.6.1. Design of guide RNA (sgRNA)  
In order to generate deletions of selected poised enhancers, pairs of sgRNA 
were designed flanking each candidate poised enhancer according to the 
instructions of the genome engineering toolbox from Zang lab 
(http://www.genome-engineering.org/crispr/). To minimize potential off-targets, 
all selected gRNAs displayed on-target scores >80 and potential off-targets 
with scores <7 (in most cases off-target scores were <1). Furthermore, the 
sequence was truncated to be 19 bp long and a G was added at the 5’ end 
since that was reported to help the specificity of the gRNAs (Fu et al. 2014). 
For each selected sgRNA, two oligonucleotides were synthesized carrying the 
ends of BbsI restriction enzyme (Table 3.17). Complementary oligos were 
annealed by incubation at 95°C for five minutes and subsequent cooling to 
25°C at a cooling rate of 5°C/min. The next annealing reaction was performed: 
 
1 µl  oligo 1 (100µM)  
1 µl  oligo 2 (100µM)  
1 µl  10X T4 Ligation Buffer (NEB)  
7 µl  ddH 2 O  
10 ul  total 
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Table 3.17: gRNAs used for CRISPR-Cas9 and oligos for vector cloning 
 
 
 
 
 
 
Name gRNA with PAM domain Oligo F (5'-3') Oligo R (5'-3') 
PE_Six3_ left CCTGACTTCTCGTAGACTCC-TGG caccGTGACTTCTCGTAGACTCC aaacGGAGTCTACGAGAAGTCAC 
PE_Six3_ right GGACCTTTCTGGACGCTGAT-AGG caccGACCTTTCTGGACGCTGAT aaacATCAGCGTCCAGAAAGGTC 
PE_Sox1_ left ATTGCCTCCTGCGCGTGGCA-TGG caccGTGCCTCCTGCGCGTGGCA aaacTGCCACGCGCAGGAGGCAC 
PE_Sox1_ right GGCTTCTGAAGTGGGGCGTC-TGG caccGCTTCTGAAGTGGGGCGTC aaacGACGCCCCACTTCAGAAGC 
PE_Lhx5_ left TCTTTCAGCGATGATCCGGG-AGG caccGTTTCAGCGATGATCCGGG aaacCCCGGATCATCGCTGAAAC 
PE_Lhx5_ right AGCGCGCTTAACAAGCATTA-CGG caccGCGCGCTTAACAAGCATTA aaacTAATGCTTGTTAAGCGCGC 
PE_Sox21_ left TGCGCACAGATCCCGACGCT-GGG caccGCGCACAGATCCCGACGCT aaacAGCGTCGGGATCTGTGCGC 
PE_Sox21_ right GTCCAAGGAAGTAACCGCAA-GGG caccGCCAAGGAAGTAACCGCAA aaacTTGCGGTTACTTCCTTGGC 
PE_Wnt8b_ left TATGTGTAGGCTCACCAGCC-AGG caccGTGTGTAGGCTCACCAGCC aaacGGCTGGTGAGCCTACACAC 
PE_Wnt8b_ right CACTAATAGGTGTCCTCGTC-CGG caccGCTAATAGGTGTCCTCGTC aaacGACGAGGACACCTATTAGC 
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3.6.2. Generation of guide RNA (sgRNA) Cas9 vector  
The CRISPR-Cas9 expression vector pX330-U6-Chimeric_BB-CBh-hSpCas9 
or pX330-hCas9-long-chimeric-grna-g2p  was digested with BbsI and column 
purified.  
1 µg  vector 
1 µl BbsI  
2 µl  2.1 Buffer  
X µl  ddH2O        
µl  total 
 
A dilution 1:200 of the pair of annealed oligos and 50 ng of the digested vector 
were ligated overnight at 16°C using T4 ligase. For heat shock transformation 
reaction, 30µl of chemically competent E.coli (TOP10) (Table 3.9) bacteria 
were thaw on ice and mixed with 2.5 µl of the ligation reaction. After tapping 
the tube three times, bacteria solution was incubated 1 minute on ice, followed 
of heat shock for 1 minute at 37°C and another 1 minute incubation on ice. 
Afterwards, solution was transferred to 1ml TB Medium and incubated 1 hour 
at 37 °C with shaking. 200 µl of this liquid culture were plated in LB ampilicine 
plates in order to obtain bacteria colonies that were analized by PCR to 
determine if they carried the plasmid of interest (3.9.3). 
 
3.6.3 Miniprep 
The gRNA-Cas9 expression vectors were purified following the instructions of 
a comertial kit (Table 3.4) and sequenced to confirm that the gRNAs were 
correctly cloned.   
3.6.4 Transfection of mESCs 
 
mESC were grown on gelatin-coated 12 well or 6 well plates with standard 
mESCs cell culture conditions. Cells were transfected using X-tremeGENE HP 
DNA transfection reagent according to the manufacturer’s instructions with two 
sgRNA Cas9 vectors carrying gRNAs flanking the PE regions for posterior 
deletion. Transfection efficiency was checked by GFP signal 16 hours later. 
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When transfection efficiency was between 40-70%, puromycin selection was 
performed for 48 hours at 2µg/ml concentration. Afterwards, surviving cells 
were isolated in 96-well plates by serial dilution and, after expansion; clones 
with the chosen deletions were identified by PCR (see methods 3.9.4). Using 
the primers listed in table 3.18. 20-40, mESC clones were investigated by PCR 
for each PE candidate. Sanger sequencing in all the PE-/- or PE +/- clonal 
mESC lines corroborated PE deletions. In order to explore how the PE 
deletions affected the induction of their target genes towards AntNPC 
differentiation, mESC lines with PE deletions were compared to WT mESC in 
differentiations performed in parallel. This comparison corrected for technical 
bias between differentiations.  
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Table 3.18: Primers used to detect deletions generated by CRISPR-Cas9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Primer name Sequence Product 
size (bp) 
Deletion  
size (bp) 
Outcome size (bp) 
Homozygous 
deletion 
PE_Lhx5_del_F CCACCTTAGGGCTGATCAAA 795 555 240 
PE_Lhx5_del_R TGTGCCCTGGATTTCTCTTC       
PE_Sox21_del_1F ATGGGCAAGCAAAGAGAAGA   1400   
PE_Sox21_del_2R GCCAGAGTTGGAAAGTGAGC (1+2) 2324   924 
PE_Sox21_del_3R GCCTCGGGGTGTTTACAGAA (1+3) 713   No band 
PE_Sox1_del_1F CAAGAATTCCACCCTCATCC   5500   
PE_Sox1_del_2R TCTGTGAAGGGAGCTGAGGT (1+2) 5994   494 
PE_Sox1_del_3R TGGAATGTATCGGAGGGGAC (1+3) 666   No band 
PE_Six3_del_1F TTGAATCCTTTGGCCTCATC   5200   
PE_Six3_del_2R ACCACAAGAACCCACCAGAG (1+2) 6318   1118 
PE_Six3_del_3R ATTAAAAACAGCAGTGCCCCA (1+3) 938   No band 
PE_Wnt8b_del_F GGGGTCCTGAGAAGTGACAA 1433 1200 233 
PE_Wnt8b_del_R GTGTGGCTTCCTGCACTGTA       
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3.7- Circular chromatin conformation capture (4C) 
 
3.7.1- 4C library generation  
 
Circular Chromatin Conformation Capture assays were performed as 
previously reported (Splinter et al. 2012; Stadhouders et al. 2013) with minor 
modifications. 107 mESC or AntNPCs were crosslinked with 1% formaldehyde 
during 20 minutes and quenched with 0.125M glycine (final concentration) for 
additional 10 min. Cells were rinsed with PBS and proteinase inhibitors and 
resuspended in lysis buffer (Table 3.3) during 10 min on ice.  After 5 min 
centrifugation at 650g (4 °C), chromatin was re-suspended in 0.5 ml of 1.2X 
restriction buffer with 0.3% SDS and incubated at 37 °C and 900 rpm for 1h. 
Then, Triton X-100 was added to a final concentration of 2% followed by 
incubation at 37 °C and shaking at 900 rpm during 1h. Subsequently, 
chromatin was digested at 37 °C overnight while shaking (900 rpm) with 400 U 
of NlaIII. The inactivation of the enzyme was performed by adding SDS to a 
final concentration of 1.6% followed by incubation during 20 min at 65 °C and 
900 rpm. The digested chromatin was transferred to 50-ml tubes and 6.125 ml 
of 1.15X ligation buffer (Table 3.3) was added. After addition of Triton X-100 
(1% final concentration) chromatin was incubated for 1 h at 37 °C (shaking 
gently). The choice of the restriction enzymes depends on the distance 
between target and viewpoint, in this case, target gene and poised enhancer. 
Usually, the fragment should be preferentially located within the viewpoint and 
have a size around 500 bp (Splinter et al. 2012). To get a better resolution map 
and sequence depth (broad range of contacts), two four base pair cutters 
(NlaIII and DpnII) were chosen. After Triton incubation, digested chromatin was 
ligated with 100 U of T4 DNA ligase for 8 h at 16 °C. RNAse A was added (300 
µg) for 45 min at 37 °C and afterwards, chromatin was de-crosslinked with 300 
µg of Proteinase K and overnight incubation at 65 °C. Phenol/chloroform 
extraction followed by ethanol precipitation was used to purify DNA followed by 
re-suspension in 100 µl of water. Digestion and ligation efficiencies were 
evaluated by running a small fraction of the purified DNAs on an agarose gel 
(Figure 3.1). DNA obtained from the previous step was digested with 50U of 
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was digested with 50U of DpnII in 500 µl of 1x NEB DpnII buffer at 37 °C 
overnight. Afterwards, DNA was purified by phenol/chlorophorm extraction, 
followed by ethanol precipitation. Samples were re-suspended in 500 µl of 
water and a second ligation was performed. In order to increase the contacts in 
proximity, ligation was carried out in a final volume of 14 ml of water 
supplemented with 1X ligation buffer (Table 3.3) and 200 U of T4 DNA Ligase 
were added. After overnight incubation at 16 °C, DNA samples were again 
purified by phenol/chlorophorm extraction and ethanol precipitation, re-
suspended in 100 µl of water and finally isolated with a QIAgen PCR 
purification column (Table 3.4). The efficiencies of the second digestion and 
ligation were also evaluated by agarose electrophoresis (Figure 3.1). 
 
 
 
 
 
 
 
 
 
Figure 3.1: Analysis of digestion and ligation of the 4C protocol. A, 1,5% agarose 
electrophoresis gel. 1: undigested DNA. 2: digested DNA with NlaIII 3,4 ligated DNA 
after digestion with Nla III. 5, 6: digested DNA with DpnII. 7: Ligated DNA after 
digestion with DpnII.	  
 
 
3.7.2- 4C -seq 
The resulting 4C DNA products were amplified by inverse PCR (3.9.5) using 
primers described in table 3.19, and run into a 1,5 % agarose gel. When the 
pattern was the expected (one prominent band product of self ligation and a 
broad smear, (Figure 3.2), samples were sent for sequencing to the Erasmus 
Medical Center in Rotterdam (Netherlands). 4C libraries were prepared 
according to Illumina protocol and the resulting reads from the sequencing 
facility were then mapped and analyzed with R3C-seq (Thongjuea et al. 2013) 
4       5                  6     7                1     2       3              
5000 
1000 
500 
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to identify contacts between our viewpoints (poised enhancers) and other 
genomic loci.  
 
 
 
	  
	  
	  
	  
	  
 
 
 
Figure 3.2: Pool of 4C-PCR reactions: 1,5% agarose gel for a pool of five 4C 
reactions to be further sequenced. The pattern shows a prominent band, product of 
the self-ligation, a secondary band, which could be unspecific products or re ligated 
products and a broad smear representing the 4C contacts.  
 
3.7.3 - 3C validation of 4C-seq results.  
3C (DNA samples obtained after first ligation of the 4C protocol) and 4C 
samples were prepared as previously described, using NlaIII and NlaIII+DpnII 
as restriction enzymes, respectively.  Fragments located within the PEs and 
gene promoter were used to design 3C primers in NlaIII areas of interest, 
typically around 100 bp away from a NlaIII site and without DpnII sites in 
between (Table 3.20). This strategy warranted that the same primers could be 
used to analyze both 3C and 4C samples. As a loading control, a set of PCR 
primers which amplify a 200 bp fragment without NlaIII sites at the Tbp locus 
were also designed. Primer sequences and the expected product sizes can be 
found in table 3.20.  
 
To generate the 3C control library, two ~2000 bp fragments per viewpoint locus 
were amplified by PCR. Some of these 2000 bp fragments contained our PE 
sequences (i.e. the 4C-seq viewpoint) and the others, the promoters of the PEs 
cognate genes (Table 3.21). The 2000 bp fragments contained several NlaIII 
sites. In addition, we also included the ~200 bp loading control Tbp, which was 
not digested by NlaIII. PCR products were digested with NlaIII overnight 
1000 
5000 
500 
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followed by a round of phenol/chlorophorm purification. Afterwards, they were 
mixed in equimolar concentration (nanomolar range), ligated and purified. This 
control library covered all the chimeric products expected to be obtained with 
the 3C primers in high concentration. The control library was used to test the 
specificity and efficiency of the 3C primers by performing serial dilutions PCRs 
(see methods 3.9.6). 
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Table 3.19: Primers used for 4C-seq 
 
 
 
  Viewpoint Illumina adaptor Barcode Primer 5'  --> 3' Complete sequence  
p5 
(1): PE Six3  
AATGATACGGCGACCACCGAACACTC
TTTCCCTACACGACGCTCTTCCGATCT TGACCA 
GGGGCGCTCCTTCT
TTTT 
AATGATACGGCGACCACCGAACACTCTTTCCCTACACGA
CGCTCTTCCGATCTTGACCAGGGGCGCTCCTTCTTTTT 
p5 
(2): PE Six3  
AATGATACGGCGACCACCGAACACTC
TTTCCCTACACGACGCTCTTCCGATCT ACATGT 
GGGGCGCTCCTTCT
TTTT 
AATGATACGGCGACCACCGAACACTCTTTCCCTACACGA
CGCTCTTCCGATCTACATGTGGGGCGCTCCTTCTTTTT 
p7:  PE Six3  CAAGCAGAAGACGGCATACGA   
CGGCTTGTTTACCG
CTTTAAT 
CAAGCAGAAGACGGCATACGACGGCTTGTTTACCGCTTT
AAT 
p5 
(1): PE Lhx5  
AATGATACGGCGACCACCGAACACTC
TTTCCCTACACGACGCTCTTCCGATCT GCCAAT 
CGGGGGTCTGATTA
AAGGTC 
AATGATACGGCGACCACCGAACACTCTTTCCCTACACGA
CGCTCTTCCGATCTGCCAATCGGGGGTCTGATTAAAGGT
C 
p5 
(2): PE Lhx5  
AATGATACGGCGACCACCGAACACTC
TTTCCCTACACGACGCTCTTCCGATCT CTAGCT 
CGGGGGTCTGATTA
AAGGTC 
AATGATACGGCGACCACCGAACACTCTTTCCCTACACGA
CGCTCTTCCGATCTCTAGCTCGGGGGTCTGATTAAAGGT
C 
p7:  PE Lhx5  CAAGCAGAAGACGGCATACGA   
GGGAGGGGGTTTAC
AAACTT 
CAAGCAGAAGACGGCATACGAGGGAGGGGGTTTACAAA
CTT 
p5 
(1): PE Sox1  
AATGATACGGCGACCACCGAACACTC
TTTCCCTACACGACGCTCTTCCGATCT CTTGTA 
AAACTGGCCGGCTG
AATAG 
AATGATACGGCGACCACCGAACACTCTTTCCCTACACGA
CGCTCTTCCGATCTCTTGTAAAACTGGCCGGCTGAATAG 
p5 
(2): PE Sox1  
AATGATACGGCGACCACCGAACACTC
TTTCCCTACACGACGCTCTTCCGATCT GCCAAT 
AAACTGGCCGGCTG
AATAG 
AATGATACGGCGACCACCGAACACTCTTTCCCTACACGA
CGCTCTTCCGATCTGCCAATAAACTGGCCGGCTGAATAG 
p7:  PE Sox1  CAAGCAGAAGACGGCATACGA   
GGGGAATACTGGCT
GGTAGC 
CAAGCAGAAGACGGCATACGAGGGGAATACTGGCTGGT
AGC 
p5 
(1): PE Lmx1b  
AATGATACGGCGACCACCGAACACTC
TTTCCCTACACGACGCTCTTCCGATCT ATCACG 
TTCGCAATGCAAAG
CATCTA 
AATGATACGGCGACCACCGAACACTCTTTCCCTACACGA
CGCTCTTCCGATCTATCACGTTCGCAATGCAAAGCATCT
A 
p5 
(2): PE Lmx1b  
AATGATACGGCGACCACCGAACACTC
TTTCCCTACACGACGCTCTTCCGATCT TGACCA 
TTCGCAATGCAAAG
CATCTA 
AATGATACGGCGACCACCGAACACTCTTTCCCTACACGA
CGCTCTTCCGATCTTGACCATTCGCAATGCAAAGCATCT
A 
p7:  PE Lmx1b  CAAGCAGAAGACGGCATACGA   
CCTCACACAGGGAG
ACCACT 
CAAGCAGAAGACGGCATACGACCTCACACAGGGAGACC
ACT 
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Table 3.20: 3C Primers used for 3C validation of 4C 
 
Table 3.21: Template primers used for 3C validation of 4C 
Primer name Sequence 
4cval_temp_six3_Pr_F CTCCAGTTGGGTTCACGTTT 
4cval_temp_six3_Pr_R GGAGGAGGAAGGACGTAAGG 
4cval_temp_six3_Enh_F ATGGCTATTGCTCCACCAAG 
4cval_temp_six3_Enh_R AAGCAGGCTGCCTTGAAATA 
4cval_temp_Lmx1b_Pr_F TAAAACAACTCCGCGCTTCT 
4cval_temp_Lmx1b_Pr_R CGTTGAAGTGGCTGACTGAA 
4cval_temp_Lmx1b_Enh_F GGTGACAGTTACCCGCAGTT 
4cval_temp_Lmx1b_Enh_R CAGCCTTCAGGAGAGAGAGC 
4cval_temp_Sox1_Pr_F TGCCAGGGAATGTAAACACA 
4cval_temp_Sox1_Pr_R GTCCCCAGAACATGAGTGCT 
4cval_temp_Sox1_Enh_F CCAGCCTCTTAATCCAGTGC 
4cval_temp_Sox1_Enh_R CAGCTTTGTGAAGCCATTGA 
4cval_temp_Lhx5_Pr_F CACCACGTCACCAAATCTGA 
4cval_temp_Lhx5_Pr_R AGCAGAAGAATGGGAGCAGA 
4cval_temp_Lhx5_Enh_F CTGCCAGAGGAGGAAATGAG 
4cval_temp_Lhx5_Enh_R AATGAGGAAGCTGGGGTTCT 
 
 
 
Primer name Sequence Distance 
to NlaIII 
site (bp) 
Expected 
size product 
(bp) 
3Cval_Six3_enh CCTGCTTAACGGGGAAATTG 104 192 
3Cval_Six3_pr TCGCAAGTCATCTTCAATCG 88   
3Cval_Sox1_enh CATTAATCTGGGAACAAACAGCTAA 115 195 
3Cval_Sox1_pr CAGACAGACAAACTTTCTCCATTTT 80   
3Cval_Lmx1b_enh GGTGACAGTTACCCGCAGTT 111 176 
3Cval_Lmx1b_pr GACCACAGCCTTGGATTCAT 65   
3Cval_Lhx5_enh CCAGCTCTCCAGCTCATTTT 62 181 
3Cval_Lhx5_pr TAGCTCGGCAAAGGAGAAAG 119   
NEGATIVE 
CONTROL 
      
3Cval_Sox1_enh CATTAATCTGGGAACAAACAGCTAA 115 203 
3Cval_Six3_pr TCGCAAGTCATCTTCAATCG 88   
LOADING 
CONTROL 
      
Tbp_F ACAACAGCAGGCAGTAGCAA NA 193 
Tbp_R TGGTGTGGCAGGAGTGATAG NA   
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3.8 - Enhancer reporter assays 
These experiments were performed using a previously described system 
based on PiggyBac transposon (Respuela et al. 2016; Cruz-Molina et al. 
2017). Basically, this method consisted in amplifying by PCR the PE 
sequences of interest (PE Lhx5 (-109) and PE Wnt8b (+21)) (Table 3.22) and 
clone them afterwards in front of a minimal TK promoter driving GFP 
expression. Then, WT mESC were transfected with Super PiggyBac 
Transposase vector and the resulting PE PiggyBac reporter vectors (Table 
3.10) using X-tremeGENE HP DNA transfection reagent according to the 
manufacturer’s instructions. 48 hours after transfection, neomycin (0.2 mg/ml) 
was added to the medium to select cells that incorporated the reporter vector 
in a stable way. After one week of neomycin selection, the surviving cells 
were expanded and differentiated afterwards into AntNPC. The negative 
control for this experiment was a mESC line, also transfected with an empty 
PiggyBac reporter vector. The levels of GFP were evaluated using a Nikon 
Microscope ECLIPSE TS100 coupled with Nikon intense light C-HGFI for 
florescence illumination (Table 3.1).  
 
Table 3.22: Primers used for amplification of PEs in reporter assays. 
Primer name Sequence Product 
size(bp) 
Wnt8b_PE_BamhI_5 AAAAAAGGATCCAGAGAAAGGCTCCTCCTTGG 1208 
Wnt8b_PE_EcoRI_3 AAAAAAGAATTCAACTGAACCTGCGTCCTTTG   
Lhx5_PE_BamhI_5 AAAAAAGGATCCCTGGCTTTTCAAGGAAGCTG 896 
Lhx5_PE_EcoRI_3 AAAAAAGAATTCCCTTGTCTTGTCTGGTGCAC   
 
3.9- Polymerase Chain Reaction (PCR) 
3.9.1- RT-qPCR 
In order to determine the transcript levels of our cells, RNA was extracted and 
cDNA was produced as described above (3.4.2 and 3.4.3). Prior to RT-qPCR, 
samples were diluted 1:5 in water and 0,5 µl of this dilution were used per 10 
µl reaction (master mix per sample: 5 µl ORA qPCR Green ROX L Mix  (2x), 
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0,125.µl 20µM primer mix and 4,375 µl dH20). PCR reactions were performed 
in 396 well plates on the Light Cycler 480II (Roche) with the program “SYBR 
Green I 384 II” (Table 3.23) using Eef1a1 and Tbp as housekeeping genes 
(Table 3.24). Analysis of the resulting amplification curves was performed with 
the second derivative maximum method implemented in the LightCycler 
software. All the measurements were performed as triplicates and standard 
deviations were represented as error bars.  
Table 3.23: RT-qPCR program  
Step  Temp  Time  
Initial 
Denaturation  
95°C  5 minutes  
45 Cycles  95°C 
60°C 
72°C  
10 seconds 
10 seconds 
10 seconds 
Melting curve 95°C 
65°C 
5 minutes 
1 minute 
Hold  4-10°C    
Table 3.24: RT-qPCR primers  
Primer name Sequence 
Eef1a1_cDNA_F TAGACGAGGCAATGTTGCTG 
Eef1a1_cDNA_R AGCGTAGCCAGCACTGATTT 
Tbp_cDNA_F TTCGTGCAAGAAATGCTGAA 
Tbp_cDNA_R TCCTGTGCACACCATTTTTC 
Zfp42_cDNA_F GCGGTGTGTACTGTGGTGTC 
Zfp42_cDNA_R GACAAGCATGTGCTTCCTCA 
Six3_cDNA_F CCTCACCCCCACACAAGTAG 
Six3_cDNA_R CTGATGCTGGAGCCTGTTCT 
Wnt8b_cDNA_F ACTCCCGAAATGGACAACTG 
Wnt8b_cDNA_R CTGCTTGGAAATTGCCTCTC 
Lxh5_cDNA-F CGGGAAGGCAAGCTATACTG 
Lhx5_cDNA-R CAGGTCGCTCGGAGAGATAC 
Sox1_cDNA_F TCGAGCCCTTCTCACTTGTT 
Sox1_cDNA_R CAACCCAAAAGAGCGGTAAC 
Sox21_cDNA_F CTCTCCTCTCCTGTGCCAAA 
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Sox21_cDNA_R GGAACCCCCAATCCTGTAGT 
Lmx1b_cDNA_F GGGATCGGAAACTGTACTGC 
Lmx1b_cDNA_R GTAGGGGCGATCTTCTCCAT 
Emx2_cDNA_F GCACGCTTTTGAGAAGAACC 
Emx2_cDNA_R GTTCTCCGGTTCTGAAACCA 
T_cDNA_F TGCTGCAGTCCCATGATAAC 
T_cDNA_R CCATTGCTCACAGACCAGAG 
Six3_cDNA_AS_F GCTGTACTGGCCTCTTCTGG 
Six3_cDNA_AS_R AAAGGGCCAAGGAATGATCT 
Lmx1b_cDNA_AS_F GACCACAGCCTTGGATTCAT 
Lmx1b_cDNA_AS_R CTTCGGTTCTTGAGGCAGAG 
Lhx5_cDNA_AS_F GATAATTCAAGGCGGCAGTG 
Lhx5_cDNA_AS_R TGTCTGGTCAGCAAGCAATC 
Sox21_cDNA_AS_F AGCAGTGGCATGTTAAGTGG 
Sox21_cDNA_AS_R GCAACAGGAGAGCAAAAACA 
Sdsl_cDNA_F CTCCGTGCAGGTGGTGAG 
Sdsl_cDNA_R ACATTGGCTTCATCCCAGAC 
Camkmt_Six3_cDNA_F GAGCCCATTTCAAACTTCCA 
Camkmt_Six3_cDNA_R AAGCAGAAGTGGGTAGTGCAG 
Spaca7_Sox1_cDNA_F TCTGTCTTCCTGCTGTGCTG 
Spaca7_Sox1_cDNA_R TGCTTCGGGTATGTTTTCTG 
Sec31b_wnt8b_cDNA_F GAAGCACACTGGAGCTGTCA 
Sec31b_wnt8b_cDNA_R GGTGGTTCAAATCCCAAATG 
Gpr180_sox21_cDNA_F GGTCATCACAGTGGAGAGGAG 
Gpr180_sox21_cDNA_R TCATTAAAAGCGACAGCAATG 
GSC_cDNA_F CAGGAGACGAAGTACCCAGAC 
GSC_cDNA_R AGGAGGATCGCTTCTGTCG 
Fez2f_cDNA_F GGCTACAAGCCCTTCGTCT 
Fez2f_cDNA_R TGTGGGTGAGCTTGTGATTC 
Mixl1_cDNA_F CGACAGACCATGTACCCAGA 
Mixl1_cDNA_R GGCTGAAATGACTTCCCACT 
mPax6_cDNA_F CTTGGGAAATCCGAGACAGA 
mPax6_cDNA_R CTAGCCAGGTTGCGAAGAAC 
Tubgcp3_cDNA_ SOX1_F CTCACTGACATCCGGAAAGG 
Tubgcp3_cDNA_ 
SOX1_R ATCTCTGAGGCCAGGATGTG 
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Atp11a_cDNA_ SOX1_F CCACCGTCTTTATGCTTTCC 
Atp11a_cDNA_ SOX1_R GGGGTGAATTCTGAAATGCT 
Ndufb8_cDNA_Wnt8b_F GGGACCACTCAGAACTCAGG 
Ndufb8_cDNA_Wnt8b_R CATGACATCCCAGGACACAG 
Hif1an_cDNA_Wnt8b_F TTGAGAAGATGCTTGGAGAGG 
Hif1an_cDNA_Wnt8b_R CGGCCTTTAATCATGGTGTT 
Prep1_cDNA_Six3_F GGAACCACGTGATTGAGGAT 
Prep1_cDNA_Six3_R GCATCAGTGCTGTCAAGTCC 
Six2_cDNA_Six3_F GCAAGTCAGCAACTGGTTCA 
Six2_cDNA_Six3_R TGGAGTTCTCGCTGTTCTCC 
Gm9366_cDNA_Sox21_F CATCACTCAGCGTCGAAGAA 
Gm9366_cDNA_Sox21_R CACAGGACGTTTTCCAATCC 
Tgds_cDNA_Sox21_F TAGGATGGAAGCCCAAAGTG 
Tgds_cDNA_Sox21_R TGGACTGGAAAGGGCTCTAA 
 
3.9.2- ChIP-qPCR 
ChIP DNA samples were analyzed by q-PCR to detect the level of enrichment 
of the histone marks and P300. Input samples were diluted 1:10 and histone 
ChIP samples 1:3 prior to q-PCR. PCR conditions, program and analysis of 
the curves were the same than above (3.9.1, Table 3.23). ChIP-qPCR signals 
were calculated as percentage of input. Standard deviations were measured 
from the technical triplicate reactions and were represented as error bars. 
Each ChIP sample was normalized to the signal average obtained in the 
same sample when two different negative control regions were used 
(chr2_neg, chr6_neg) (Table 3.25). Standard deviations were calculated from 
technical triplicate reactions and represented as error bars. 
Table 3.25: Primers used in ChIP-qPCR 
Primer name Sequence 
Chr6_neg_F CTGGACTGAGGACCTTCTGC 
Chr6_neg_R AGGAAGGCAGATGAGGGATT 
Chr2_neg_F CCTGAGGCTGGAAGTTTCTG 
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Chr2_neg_R CTCCTGGGATTAAAGGCACA 
Sox2_prom_F CGCCCAGTAGACTGCACAT 
Sox2_prom_R CCCTCCCAATTCCCTTGTAT 
Zfp42_prom_Pol2_F TGCTTTCACCATTGACTTTCC  
Zfp42_prom_Pol2_R CACTGGGGATACACGCATTA 
Six3_prom_H3K27ac_F ACCACATCCTGGAGAACCAC 
Six3_prom_H3K27ac_R CTTCTCGGCCTCCTGGTAGT 
Six3_PE_H3K27ac&me3&Pol2_F GCTCACTGAAGCAGCATTTG 
Six3_PE_H3K27ac&me3&Pol2_R CCTAAGGATTGTGGGCTCAT 
Six3_prom_Pol2_F CCTCCTTTCCATCTCCTCCT  
Six3_prom_Pol2_R CGGAATACCATGGACTGACC 
Six3_enh147kb_H3K27ac_F GAGGAGGCTCAGTGTCAAGG 
Six3_enh147kb_H3K27ac_R TTGGTCACCTTTGGTTCACA 
Six3_enh7kb_H3K27ac_F ACTTACCCAGCCACCTGTTG 
Six3_enh_7kb_H3K27ac_R TTGGCTTTTGCTTTTGTGTG 
Lhx5_prom_Pol2&K27ac_F CGGGAAGGCAAGCTATACTG  
Lhx5_prom_Pol2&K27ac_R TCCCAAGGAGCCAGAGTAGA  
Lhx5_PE_H3K27ac&me3&Pol2_F ATGCCTCTCTGGCTTTTCAA 
Lhx5_PE_H3K27ac&me3&Pol2_R ATCAGCCCTAAGGTGGCTTT 
Lhx5_enh144kb_H3K27ac_F CCCCTCCCTCAATCTCTTCT 
Lhx5_enh144kb_H3K27ac_R CCAGGAAAGCCTTGGTAAAA 
Lhx5_enh61kb_H3K27ac_F GACTCCCTTGCTGTGAGACC 
Lhx5_enh61kb_H3K27ac_R GTAGCCCGCTTGGACATAAA 
Wnt8b_PE_Pol2_F GAGTGAAATGCCCCTGACAT 
Wnt8b_PE_Pol2_R AGGGAAGTATGTCCCCTGCT 
Wnt8b_prom_Pol2_F GGGATCGCTTACACACCAAG 
Wnt8b_prom_Pol2_R GGGTGAGCGACTCAAACATT 
Sox1_PE_Pol2_F CTCAAGAGCATTTTGCCACA 
Sox1_PE_Pol2_R GGGCTTGCTTCATTCTTTGA 
Sox1_prom_Pol2_F CTAGAAGTTGCGGTCCCAGA 
Sox1_prom_Pol2_R GTTCGCTGCCTCCTCTTGT 
Brpf3_2556_F GATCTCTCCTTTGGGCCTCT 
Brpf3_2556_R GGCTGGCCTTAAAATGACAA 
Calcoco2_2382_F TCAAATTCGGGGTCAGTTTC 
Calcoco2_2382_R GCCTTTCAACAATGCTCCTC 
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Chr_17neg_R GAACAGGAATGGCCACAGAT 
Chr_17neg_F CTCCTGCCCTGTGGTATGTT 
Lhx5_seqchip_p300_F GGCCCAAAACCCCTAAAATA 
Lhx5_seqchip_p300_R GGCTTCATGTGGGACCTTTA 
Six3_seqchip_p300_F GTCAGGGCTGTTGTCCAATC 
Six3_seqchip_p300_R TCTGCATCCACATTTGTTCC 
Sox1_seqchip_p300_F CCTGAAAATGATGCTGCTGA 
Sox1_seqchip_p300_R GGAGTAGCTGTGGGTGTGGT 
 
3.9.3- Colony- PCR 
In order to determine whether the bacterial colonies carry the plasmid of 
interest, PCRs were performed using One Taq DNA polymerase (Table 3.26 
and 3.27). Bacterial colonies were resuspended in 30 µl of dH20 and 20 of 
these were heated at 95°C to lysate the cells. Three microliters of the lysate 
was used per PCR reaction. The 5’-3’ oligo cloned in the vector (Table 3.17) 
was used as a forward primer and the px330-R primer from the vector as a 
reverse (ggaaagtccctattggcgtt). If PCR works, a band of 300 bp is obtained.  
 
Table 3.26: Colony- PCR master mix 
 
Component 25 µl reaction Final Concentration 
5X OneTaq Standard Reaction Buffer 5 µl 1X 
10 mM dNTPs  0.5 µl 200 µM 
10 µM Forward Primer 0.5 µl 0.2 µM 
10 µM Reverse Primer 0.5 µl 0.2 µM 
OneTaq  DNA Polymerase 0.125 µl 1.25 units/ 50µl PCR 
Template DNA 3 µl < 1,000 ng 
Nuclease-free water to 25 µl  
 
Table 3.27: Colony- PCR program  
Step  Temp  Time  
Initial 
Denaturation  
94°C  30 seconds  
30 Cycles  94°C 
63°C 
30 seconds 
30 seconds 
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68°C  1 minute/kb  
Final Extension  68°C  5 minutes  
Hold  4-10°C    
 
3.9.4- Clonal genotyping PCR 
To define the genotype of the clones obtained after transfection (3.6.4), DNA 
was isolated from them using quick DNA extract solution (Table 3.7) and PCR 
was subsequently performed (Table 3.28, 3.29). Platinum PCR was chosen 
due to its robustness (Table 3.8). 
 
Table 3.28: Clonal genotyping PCR master mix 
 
Component 25 µl reaction Final Concentration 
10X PCR Buffer without Mg 2.5 µl 1X 
50 mM MgCl2 0.75 µL 1.5 mM 
10 mM dNTPs  0.5 µl 200 µM 
10 µM Forward Primer 0.5 µl 0.2 µM 
10 µM Reverse Primer 0.5 µl 0.2 µM 
Platinum™ Taq DNA Polymerase 0.1 µl 2 U/reaction ** 
Template DNA 1 µl < 500 ng 
Nuclease-free water to 25 µl  
 
Table 3.29: Clonal genotyping PCR program used 
Step  Temp  Time  
Initial 
Denaturation  
94°C  2 minutes  
39 Cycles  94°C 
60°C 
72°C  
30 seconds 
30 seconds 
1 minute/kb  
Hold  4-10°C    
 
3.9.5- 4C –PCR 
4C samples were amplified by inverse PCR using expand long template PCR 
system and primers located within selected poised enhancers, which were 
designed as previously described (Stadhouders et al. 2013) (Table 3.30, 
3.31). The primer requirements are similar to those used in standard PCR 
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reactions, with a preferred length of the oligos between 17 and 24 nt to 
facilitate efficient amplification, and annealing temperatures are generally 
around 60°C. Primers were design with Primer 3 software 
(http://bioinfo.ut.ee/primer3-0.4.0/). First, primers without Illumina adaptors 
were tested to determine if 4C products present the expected amplification 
pattern after PCR on a gel (Table 3.19). If pattern is correct, PCR is 
performed using primers with Illumina adaptors and 1/5 of the PCR product 
was run into a gel (Figure 3.2). After checking that a shift of the size of the 
adaptors is produced in the gel pattern, the rest of the sample is purified using 
Quiagen PCR purification columns and sent for sequencing. 
 
Table 3.30: 4C –PCR master mix 
 
Component 25 µl 
reaction 
50 µl for Ilumina 
seq 
Final 
concentration 
10X PCR buffer 1 (17,5mM MgCl2) 2.5 µl 5 µl 1X 
10 mM dNTPs  0.5 µl 1 µl 200 µM 
35 pmol/µl Forward Primer 1 µl 2µl 35 pmol 
35 pmol/µl Reverse Primer 1 µl 2µl 35 pmol 
Expand Long Template 
Polymerase 
0.35 µl 0,7 µl 3.75 U 
Template DNA Depends 
on 
concentrat
ion 
Depends on 
concentration 
150 ng 
Nuclease-free water to 25 µl   
 
Table 3.31: 4C –PCR Program used 
Step  Temp  Time  
Initial 
Denaturation  
94°C  2 minutes  
30 Cycles  94°C 
60°C 
68°C  
10 seconds 
1 minute 
3 minutes  
Final extension 68°C 5 minutes 
Hold  4-10°C    
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3.9.6 – 3C-PCR validation of 4C  
Control template library and 3C PCR amplifications were performed with the 
Platinum Taq polymerase using the following components and program 
(Table 3.32, 3.33):  
Table 3.32 3C- PCR validation of 4C master mix 
 
Component 25 µl reaction Final 
Concentration 
10X PCR Buffer without Mg 2.5 µl 1X 
50 mM MgCl2 0.75 µL 1.5 mM 
10 mM dNTPs  0.5 µl 200 µM 
10 µM Forward Primer 0.5 µl 0.2 µM 
10 µM Reverse Primer 0.5 µl 0.2 µM 
Platinum™ Taq DNA Polymerase 0.1 µl 2 U/reaction ** 
Template DNA Depends on 
concentration 
< 500 ng 
Nuclease-free water to 25 µl  
 
Table 3.33 3C-PCR validation of 4C Program used 
Step  Temp  Time  
Initial 
Denaturation  
94°C  2 minutes  
4-0 Cycles  94°C 
60°C 
72°C  
30 seconds 
30 seconds 
30 seconds  
Hold  4-10°C    
*For generating control template library, the extension time was increased to two 
minutes since the amplification fragments were 2000 bp long. 
3.9.7- Agarose gel 
To determine presence and size of the PCR products, PCR samples were run 
at 85 V for 45 min in 1X TAE electrophoresis buffer using a 1-2% agarose gel, 
depending on the size of the product, and containing SYBR Safe DNA gel 
dye. Size of the PCR product was determined by loading 7µl of DNA gene 
ladder. 
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3.10 - Statistical Analysis 
3.10.1- RT-qPCR statistical analysis 
The 2ΔCt method was used to calculate relative gene expression levels. 
Standard deviations were calculated from technical triplicate reactions and 
were represented as error bars.  
3.10.2- ChIP-qPCR statistical analyses 
Technical triplicates were used to calculate ChIP signals as percentage of 
input. Each ChIP sample was normalized to the average signals obtained in 
the same sample when using different control regions (see figures for more 
details). Standard deviations were calculated from technical triplicate 
reactions and represented as error bars. 
3.10.3- RNA-seq analysis 
RNA-seq data were analyzed using a high-throughput next-generation 
sequencing analysis pipeline (Wagle, Nikolić, and Frommolt 2015) (see recent 
publication for more details (Cruz-Molina et al. 2017)). In order to measure the 
genes differentially expressed between WT, PE Lhx5-/- and EED-/- AntNPCs, 
four biological replicates for WT, two replicates for two different PE Lhx5 (-
109)-/- clones (clone one and two) and four biological replicates for EED-/-  
were used.  
3.10.4- ChIP-seq analysis 
ChIP-seq sequencing experiments were performed for P300 and various 
histone modifications in mESCs grown serum + LIF, AntNPCs and 2i mESCs. 
ChIP sequencing reads were mapped to the mouse genome (mm10 
assembly) using BWA (Li et al. 2013). Afterwards, a bioinformatics pipeline 
was applied in order to identify genomic regions significantly enriched in the 
investigated histone marks and proteins in comparison to the total genomic 
input DNA (see (Cruz-Molina et al. 2017) for further details). 
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3.10.5- 4C-seq analysis 
4C- PCR samples were sequenced at Erasmus Medical Center (Rotterdam) 
using HiSeq 2500 system. The reads were aligned to the mouse genome 
(mm9 assembly) using Bowtie (Langmead et al. 2009). To generate reads per 
million (RPM), the resulting mapped reads were evaluated with R3C-seq 
(Thongjuea et al. 2013). Information about 4C-seq library generation, analysis 
and quantification of 4C signals has been previously described (Cruz-Molina 
et al. 2017). 
 
3.10.6- Public datasets and additional bioinformatics analysis 
The following publically available ChIP-seq datasets were used in this study 
(Attanasio et al. 2014; Kagey et al. 2010; Nord et al. 2013; Chen et al. 2008; 
Ku et al. 2008; Ma and Wong 2011; Marson et al. 2008).  
 
- In mESC: OCT4/POU5F1 (GSM307137), SOX2 (GSM307138, 
GSM3071389), NANOG (GSM307140, GSM307141), PRDM14 
(GSM623989), RING1B (GSM656523), SUZ12 (GSM288360), EZH2 
(GSM327668), MED1 (GSM560347), MED12 (GSM560345), SMC1 
(GSM560341), SMC3 (GSM560343), CTCF (GSM560352). From 
E11.5.  
- In E14.5 mouse embryos: E11.5 forebrain H3K27ac (GSM1264352), 
E14.5 forebrain H3K27ac (GSM1264356), E11.5 liver H3K27ac 
(GSM1264386), E14.5 liver H3K27ac (GSM1264388), E11.5 limb 
H3K27ac (GSM1371056). 
 
To evaluate the in vivo enhancer activity of poised enhancers identified in 
mESCs, we compared our list of mESCs poised enhancers with highly 
conserved sequences included in the Vista Enhancer Browser (Visel et al. 
2009) whose in vivo enhancer activity was previously evaluated in E11.5 
mouse embryos. (See (Cruz-Molina et al. 2017) for additional details).  
 
GREAT (McLean et al. 2010) was used to perform the in-silico functional 
annotation of different groups of enhancers . 
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Further details regarding the computational analyses used to identify 
AntNPCs superenhancers, identify motifs overrepresented among poised 
enhancers, determine the overlaps between CpGs and PEs, etc can be found 
in (Cruz-Molina et al. 2017).  
 
3.10.7 -Data and Software Availability 
The ChIP-seq, RNA-seq, and 4C-seq datasets reported in this dissertation 
have been deposited in the Gene Expression Omnibus (GEO) repository and 
are publically available under the accession number GSE89211. 
3.10.8 – Software and algorithms 
Table 3.34: Software and algorithms 
 
 
Software Source Identifier 
BWA Li and Durbin, 2009 http://bio-bwa.sourceforge.net/ 
MACS2 Zhang et al., 2008 http://liulab.dfci.harvard.edu/MACS/ 
Galaxy Afgan et al., 2016 http://main.g2.bx.psu.edu/ 
deep Tools  Ramírez et al., 2014 http://deeptools.ie-freiburg.mpg.de/ 
GREAT McLean et al., 2010 http://bejerano.stanford.edu/great/public/ht
ml/ 
HOMER Heinz et al., 2010 http://homer.salk.edu/homer/motif/ 
DAVID Huang et al., 2009 https://david.ncifcrf.gov/ 
SeqPos motif 
tool 
Liu et al., 2011 http://cistrome.dfci.harvard.edu/ap/ 
AME (Analysis 
of Motif 
Enrichment) 
McLeay and Bailey, 
2010 
http://meme-suite.org/tools/ame 
R3C-seq   Thongjuea et al., 2013 http://bioconductor.org/packages/release/bi
oc/html/r3Cseq.html 
Bowtie Langmead et al., 2009 http://bowtie-bio.sourceforge.net/ 
seqPattern  Bionconductor http://bioconductor.org 
Results  
	   66	  
4- RESULTS 
 
4.1- Identification and characterization of PEs in mESCs 
 
Different classes of enhancers can be identified based on unique chromatin 
signatures. As first step to identify active, primed and poised enhancers in 
mESCs, we performed ChIP-seq experiments in mESCs grown under serum 
plus LIF for H3K4me1, H3K4me3, H3K27me3, H3K27ac and P300 (see 
methods 3.5.1). Using the criteria described in Table 1.1, (Cruz-Molina et al. 
2017; Rada-Iglesias et al. 2011), three non overlapping set of enhancers were 
defined: 12142 active enhancers, 19793 primed enhancers and 1015 poised 
enhancers (Figure 4.1).  
 
 
Figure 4.1: Identification of active, primed and poised enhancers in mESCs 
grown under serum plus LIF. (A-C) Average ChIP-seq signals for H3K27me3, 
H3K27ac, H3K4me1 and H3K4me3 are showed around (A) 12142 active enhancers 
(B) 19723 primed enhancers and (C) 1015 poised enhancers. (D-E) Genome 
browser representation of P300, H3K4me1, H3K4me3, H3K27me3 and H3K27ac 
ChIP-seq profiles in mESC are shown around (D) a representative active enhancer 
(covered in pink) located five prime of Zfp42 and (E) a primed enhancer located 
downstream of the Hhex gene covered in blue. 
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4.1.1- PE signature in pluripotency 
In order to identify PEs in ESC, mESCs were used as a model due to the fact 
of their high genetic tractability and clonogenicity. In mESCs several 
pluripotency states have been defined. Epiblast cells within the mouse pre-
implantation embryo display naïve or ground state pluripotency, which can be 
maintained in vitro using the so-called 2i conditions (mixture of GSK3 and 
MEK inhibitors) (see methods 3.32 and 3.33). Naïve pluripotency is 
characterized by an homogeneus gene expression profile, DNA 
hypomethylation and low levels of H3K27me3 (Galonska et al. 2015; Guo et 
al. 2016; Marks et al. 2012). Upon implantation, the epiblast cells progress 
towards pluripotent states with increasing signs of developmental priming and 
incipient expression of somatic lineage specifiers. In vitro, these primed 
pluripotent states are represented by epiblast-like cells (EPiLCs) and epiblast 
stem cells (EpiSCs) (Smith 2017; Hackett and Surani 2014). mESCs grown 
under serum+LIF conditions represent a more metastable state in which cell 
can switch between naïve and primed pluripotency and, consequently, display 
heterogenety in the gene expression profiles (Boroviak et al. 2015; Kalkan 
and Smith 2014; Ying et al. 2008).  
 
In principle, this heterogeneity found in serum+LIF conditions could contribute 
to the emergence of the poised enhancer signature in which both active and 
repressive chromatin features are found at the same genomic loci. Hence, to 
exclude this possibility, ChIP-seq experiments for P300, H3K4me1, 
H3K27me3, H3K27ac and H3K4me3 were performed in 2i mESCs to 
determine if PEs identified in serum+LIF mESCs show any differences in their 
chromatin features under naïve pluripotency conditions.  Importantly, PEs 
identified in serum+LIF mESCs showed a similar chromatin signature in the 
naïve state, with somehow decreased P300 and H3K27me3 levels (Figure 
4.2A, 2B and 2C). Additionally, using a more relaxed peak-calling criteria to 
analyze the 2i mESCs ChIP-seq data resulted in 54%, (550/1015) of all 
serum+LIF mESCs PEs being also identified in 2i mESC, with 85%of them 
(857/1015) being enriched in H3K27me3 (Cruz-Molina et al. 2017).  These 
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results suggest that PEs in serum+LIF mESCs are not the result of cellular 
heterogenety. 
 
Figure 4.2: Chromatin signature of PEs in naïve mESCs growing in 2i medium. 
(A-B) P300, H3K4me1, H3K4me3, H3K27me3 and H3K27ac ChIP-seq profiles are 
shown around a representative poised enhancer (shaded in green) for mESCs grown 
under serum+LIF conditions (A) and mESCs grown in 2i medium (B). (C) Average 
ChIP-seq signals for P300, H3K27me3, H3K27ac and H3K4me1 in 2i mESCs around 
the PEs identified in serum+LIF mESCs. (D) qPCR analysis of sequential ChIP 
experiments performed in mESCs. Anti-H3K27me3 was used as a primary antibody, 
followed by immunoprecipitation with anti-P300 (blue) or anti-GFP (red) as 
secondary antibodies. Four selected PEs (PE Lhx5(-109), PE Six3(-133), PE 
Sox1(+35), PE Wnt8b(+21)), two active enhancers (AE Calcoco2, AE BRPF3) and 
an intergenic negative control region (“chr17_neg”) were analyzed . The error bars 
represent standard deviation from three technical replicates.  
 
To further demonstrate that the PE chromatin signature does not arise as a 
consequence of the cellular heterogeneity, sequential ChIP-qPCR was 
performed, in serum+LIF mESCs using the H3K27me3 and P300 antibodies. 
These experiments demonstrated that P300 and H3K27me3 simultaneously 
bound the analyzed PEs candidates in serum+LIF mESC and therefore these 
marks do not appear as a product of heterogeneity (Figure 4.2D). 
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4.1.2- Distinctive features of mESCs primed, poised and active 
enhancers in mESCs 
 
In silico functional annotation of active, primed and poised enhancers was 
performed using a software called GREAT as it was previously described 
(McLean et al. 2010; Cruz-Molina et al. 2017). GREAT associates non-coding 
genomic regions with nearby genes and then statistically evaluates the over-
representation of such genes with respect to different gene ontologies and 
functional categories. These in silico analyses confirmed previous 
observations (Rada-Iglesias et al. 2011; Zentner et al. 2011), each enhancer 
class associates with a different set of genes. Active enhancers in mESCs 
were associated to pluripotency genes and also genes expressed during 
mouse pre-implantation development (Figure 4.3A). Primed enhancers were 
linked with genes expressed and involved in a broad and unrelated set of 
developmental stages and biological processes (Figure 4.3B). In contrast, 
PEs were strongly linked with genes involved in early organogenesis and the 
establishment of the basic body plan, with a clear bias towards genes 
expressed and implicated in the development of the future brain (Figure 
4.3C).  
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Figure 4.3: 
   Functional 
annotation of active 
primed and poised 
enhancers in 
mESCs. Active (A), 
primed (B) and 
poised (C) enhancers 
were functionally 
annotated in silico 
using GREAT 
(McLean et al. 2010).  
From the ten most 
represented terms of 
the following gene 
ontologies (GO), five 
terminologies are 
shown: Mouse 
Phenotype (green), 
Mouse Genome 
Informatics (MGI) 
expression (blue) and 
Biological Process 
(red). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The previous bias towards anterior neural identity genes was not exclusive to 
mESCs PEs, since similar results were obtained when hESCs PEs were re-
annotated with updated versions of GREAT (Rada-Iglesias et al. 2011). To 
test wether this preferential association of PEs with genes involved in brain 
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development was not simply the result of an in silico artifact, mESCs PEs 
were compared to H3K27ac peaks identified in mouse forebrain, limb and 
liver tissues isolated from mouse embryos at embryonic days 11.5 (E11.5) 
and 14.5 (E14.5) (Attanasio et al. 2014; Nord et al. 2013). These H3K27ac 
peaks should roughly reflect the location of active enhancers in these tissues. 
Almost 50% of the PEs overlapped with H3K27ac peaks present in at least 
one embryonic mouse tissue and, remarkably, 70% of them were only found 
in the embryonic brain (Figure 4.4A), which was in full agreement with the 
previous in silico observations. Additionally, in order to check if our PE 
sequences have enhancer activity, they were compared with the Vista 
enhancer database, which contains a set of highly conserved sequences 
whose in vivo enhancer activity has been investigated in mouse embryos at 
E11.5. 25 of our PEs overlapped with sequences found in the Vista enhancer 
database and 88% of them displayed enhancer activity in E11.5 mouse 
embryos, mostly within the developing brain (Figure 4.4B). Next, sequence 
conservation analysis revealed that mESC PEs present higher conservation 
levels among vertebrates than active or primed enhancer sequences. These 
results were in agreement with previous reports in hESCs (Rada-Iglesias et 
al. 2011) (Figure 4.4C) and with the potential relevance of PEs during the 
arrangement of differentiation gene expression programs. 
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Figure 4.4: Poised enhancers are conserved elements that preferentially 
become active during brain development (A) H3K27ac peaks identified in mouse 
embryonic tissues at E11.5 and E14.5 (Attanasio et al. 2014; Nord et al. 2013). A 
combination of H3K27ac peaks identified in brain and limb (bottom panels) or in brain 
and liver (top panels) is shown for all the peaks (left) and peaks coinciding with PEs 
(right). (B) Graphic presenting the fraction of sequences showing in vivo enhancer 
activity in mouse E11.5 embryos according to five Vista Enhancer database 
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categories defined based on the tissues where enhancer activity was detected. The 
relative abundance of all Vista enhancer sequences (n = 2,274, white) within each 
category was compared to Vista enhancer sequences overlapping with PEs (n = 25, 
green). Hypergeometric tests were used to calculate p values. (C) Average 
vertebrate PhastCons signal profiles were created around the central position of 
mESCs active (purple), primed (blue) and poised (green) enhancers. 
 
Additionally, RNA-seq experiments in mESCs grown under serum+LIF were 
performed. The expression levels of the genes associated with active, primed 
and poised enhancers were in accordance with the in silico functional 
annotation results described above (Figure 4.3). Genes linked to PEs showed 
lower expression in mESC than genes associated to either active or primed 
enhancers (Figure 4.5A). Using publically available ChIP-seq data for 
H3K27me3 in mESCs (Bernstein et al. 2006), it was found that around 40% of 
the PEs putative target genes were enriched in this histone mark, which also 
agrees with the overall low expression of this set of genes (Figure 4.5B). 
Moreover, it has been reported that PEs could be bound by TFs in mESCs 
(Rada-Iglesias et al. 2011; Zentner et al. 2011). In agreement with these 
studies, we found that PEs and active enhancers in mESCs were both bound 
to a similar extent and by pluripotency TFs while primed enhancers were not 
(Figure 4.5C). In summary, the data demonstrate that PEs are a set of higly 
conserved regulatory elements preferentially associated with genes involved 
in the establishment of anterior neural identity.  
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Figure 4.5: Poised enhancers in mESCs are bound by pluripotency TFs and are 
also linked to inactive developmental genes. (A) RNA-seq data generated in 
serum+LIF mESCs was used to calculate gene expression values (measured as 
FPKMs) and presented as boxplots for (All) all genes, (Active) genes linked to active 
enhancers, (Primed) genes linked to primed enhancers and (Poised) genes linked to 
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poised enhancers. Unpaired Wilcoxon tests were used to calculate P-values. (B) For 
the gene categories described in A, the percentage of genes whose promoters are 
marked by H3K27me3 according to (Bernstein et al. 2006)  is shown. (C) Percentage 
of Active, Primed or Poised enhancers bound by the indicated pluripotency 
transcription factors according to publically available ChIP-seq data (see Methods for 
references).  
 
4.2- Establishment of a differentiation model for mESCs 
 
Previous studies and our own recent data suggest that poised enhancers 
might control the induction of genes responsible of the earliest steps of 
somatic differentiation especially towards the anterior neural fate (Zentner et 
al. 2011; Cruz-Molina et al. 2017; Rada-Iglesias et al. 2011) (Figure 4.3C, 
4.4A and 4.4B). Therefore, we examined the functional relevance of PEs upon 
differentiation of mESC into anterior neural progenitors (AntNPCs). This 
proved to be quite challenging, since in our hands, previously reported 
differentiation protocols were inefficient and resulted in heterogeneous cell 
populations that included AntNPCs and non-neural cells (Gaspard et al. 
2009). Finally, we adapted a recently described differentiation protocol (Gouti 
et al. 2014) that with slight modifications, enabled us to obtain AntNPCs in five 
days (Methods 3.3.4). Briefly, mESCs were seeded at 10000 cells/cm2 on 
plates coated with 0,1% gelatin and grown for five days in N2B27medium. 
The first three days, N2B27 medium was supplemented with 10 ng/ml of b-
FGF, which helps inducing a postimplantation epiblast-like state. In order to 
improve the purity of the differentiation, 5µM Xav939 was added to the 
medium from day two to day five. This compound is a powerful WNT signaling 
inhibitor which was reported to facilitate the anterior neural differentiation 
(Matsuda and Kondoh, 2014) (Figure 4.6). 
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Figure 4.6: Major embryonic and extra-embryonic lineages during mammalian 
development. (A) In order to differentiate mESCs, which resemble the pluripotent 
epiblast, into AntNPCs, we used XAV939, a potent inhibitor of WNT signaling. WNT 
signaling is known to promote the formation of the primitive streak in vivo and thus 
necessary for the differentiation of epiblast cells into the mesodermal and 
endodermal lineages (adapted from (Tan, Gilmore, and Baris 2013). (B) 
Differentiation protocol followed to identify enhancers that become active in 
AntNPCs. 
 
To test if the new differentiation protocol was efficient, the expression levels of 
anterior and posterior neural genes, pluripotency markers and markers from 
non-neural lineages were measured by RT-qPCR and RNA-seq (Figure 4.7A). 
In addition, protein levels of pluripotency (OCT4) and anterior neural markers 
(LHX5, NESTIN and PAX6) were also analyzed by immunofluorescence 
(Figure 4.7B). All these experiments conclusively showed that our new 
differentiation protocol resulted in high expression of anterior neural genes, 
while the pluripotency and non-neural markers were barely expressed. 
Therefore we concluded that this new protocol efficiently derives AntNPCs. 
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Figure 4.7: Characterization of AntNPCs. (A) Gene expression levels (as FPKMs) 
were obtained by by RNA-seq in mESC and AntNPCs. Upon differentiation, there 
was a decrease in the expression of pluripotency markers, while anterior neural 
markers (forebrain/ midbrain) increased. Posterior neural genes (hindbrain, spinal 
cord) and markers of non-neural lineages (extraembryonic tissues, mesoderm, 
endoderm) were barely expressed in both conditions. (B) Representative images of 
immunofluorescence experiments performed for OCT4, PAX6, NESTIN and LHX5 in 
mESCs and AntNPCs. White bar represents 20 µm scale. 
 
4.3 – Identification of PEs that become active during anterior 
neural differentiation 
 
In order to identify mESCs PEs that become active in AntNPCs, H3K27ac, 
H3K27me3 and P300 ChIP-seq experiments were performed in AntNPCs 
(Figure 4.8). 228 out of the 1015 PEs identified in mESCs gained H3K27ac in 
AntNPCs and were considered as active in these cells (PoiAct enhancers). 
The remaining PEs that did not gain H3K27ac, retained high levels of 
H3K27me3 and lost P300. We speculate that most of these PEs, which we 
termed as PoiNoAct enhancers, transitioned to an inactive state or remained 
poised for activation at a later time point or different embryonic context.  
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Figure 4.8: PEs become active during anterior neural differentiation. (A) 
Average H3K27ac ChIP-seq signals in mESCs and AntNPCs around PoiAct 
enhancers. (B) Genome browser view of a representative PE (shaded in pink) 
showing P300, H3K27me3 and H3K27ac levels in mESCs and H3K27ac levels in 
AntNPCs. Both, the PE and its putative target gene (Lhx5) gained H3K27ac in 
AntNPCs. (C, D, E) Average ChIP-seq signal profiles for P300 (C), H3K27me3 (D) 
and H3K27ac (E) in AntNPCs around PoiAct and PoiNoAct enhancers.  
 
4.3.1- Functional annotation and characterization of PoiAct enhancers 
 
To validate the relevance of PEs in the establishment of anterior neural gene 
expression programs, the previous set of PoiAct enhancers was subject to 
additional characterization. First, PoiAct enhancers were functionally 
annotated using GREAT showing that genes associated with these enhancers 
are mostly involved in early brain development (Figure 4.9A). Then, PoiAct 
enhancers were compared with H3K27ac peaks identified in different mouse 
embryo tissues, which revealed that the majority (approx. 70%) of these 
enhancers overlapped H3K27ac peaks found in the developing mouse brain 
in comparison to the other considered tissues (Figure 4.9B). Afterwards, the 
expression of the PoiAct enhancer’s closest genes was also evaluated in 
mESCs and AntNPCs, which showed a significant up-regulation of these 
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genes in AntNPCs (Figure 4.9C). Finally, to confirm that PoiAct sequences 
possess enhancer activity, they were compared with the Vista enhancer 
database. Importantly, all PoiAct elements found in the Vista Enhancer 
database displayed enhancer activity in vivo, mostly within the developing 
brain (Figure 4.9D and E). Lastly, the enhancer activity of PoiAct enhancers in 
anterior neural cells was also confirmed using in vitro reporter assays, where 
the enhancer sequence was cloned in a vector under the presence of a GFP 
driving promotor (see methods 3.8). The outcome of these experiments 
showed clear levels of fluorescence in AntNPCs for the PE secuences studied 
(Figure 4.9F).  
 
From the list of 228 PoiAct enhancers, six candidates were selected for 
additional functional dissection based on their relative proximity to major 
anterior neural regulators, high levels of sequence conservation and presence 
of H3K27ac peaks in both AntNPCs and the embryonic mouse brain. PEs 
were named based on the relative distance to their closest genes downstream 
of the TSS (+) or upstream of TSS (-) (Table 4.1). 
 
Table 4.1: PEs selected for further characterization.  
 
 
 
 
 
 
 
PE identification Closest gene Distance TSS (Kbp) 
PE Lhx5 (-109) Lhx5 -109  
PE Six3 (-133) Six3 -133  
PE Sox1 (+35) Sox1 +35  
PE Wnt8b (+21) Wnt8b +21  
PE Sox 21 (+6.5) Sox21 +6.5  
PE Lmx1b (+59) Lmx1b +59  
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Taken together, all these experiments visibly showed that the investigated 
PoiAct sequences had considerably higher enhancer activity in AntNPCs than 
in mESCs. 
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Figure 4.9: PoiAct enhancers are preferentially associated with anterior neural 
development and display in vivo and in vitro enhancer activity. (A) Functional 
annotation of PoiAct enhancers using GREAT was performed as described in figure 
4.3. (B) H3K27ac peaks identified in mouse embryonic forebrain, limb and liver at 
E11.5 and E14.5 were combined. The percentages of H3K27ac peaks observed in 
the indicated tissues are shown for all combined H3K27ac peaks (left) or for 
H3K27ac peaks overlapping with PoiAct enhancers (right). (C) Gene expression 
values (as FPKM) were measured by RNA-seq in mESCs and AntNPC for all genes 
(All), genes linked to PEs (Poised), and genes linked to PoiAct enhancers. P values 
were obtained by Paired Wilcoxon tests. (D) Sequences from the Vista Enhancer 
browser were categorized into five different sets (explained in figure 4.4B). The 
relative abundance of all Vista Enhancer sequences (n= 2.274, white) within each 
category was compared to Vista Enhancer sequences overlapping with PoiAct 
enhancers (n=10, red). P-values were calculated by hypergeometric tests. (E) 
Representative examples of the in vivo enhancer activity of Vista enhancer 
sequences overlapping PoiAct enhancers in E11.5 mouse embryos (Visel, Rubin, 
and Pennacchio, 2009).(F) Reporter assays performed in mESCs for two selected 
PEs regions, PE Lhx5 (-109) and PE Wnt8b (+21) and for a control, an empty vector 
which did not carry any PE sequence. GFP fluorescence levels were measured in 
mESCs and in AntNPCs. White bars represent 20µm scale. 
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4.4- Identification of the putative target genes of selected PEs 
based on physical interactions  
 
To identify the putative target genes of the PE candidates, 4C-seq 
experiments were performed using PEs as viewpoints (see introduction 1.2.1 
and methods 3.7). From the six PE candidates (Table 4.1), 4C-seq 
experiments were only performed for those four located more distally from 
their closest gene (i.e. > 30 Kb), since interactions between closely located 
loci can not be accurately quantified by 4C-seq. Therefore we analyzed PE 
Lhx5 (109), PE Six3 (-133), PE Sox1 (+35) and PE Lmx1b (+59) (Figure 
4.10).  
 
As expected, 4C-seq results showed that PEs contacted their predicted target 
genes in AntNPCs when they were already active as it is shown by the pink 
peaks representing 4C contacts (Figure 4.10). Remarkably, such contacts 
were also observed in mESCs as it is ilustrated by the brown peaks (Figure 
4.10). Therefore the contacts precede the activation of both PEs and their 
target genes which suggests the existence of a pre-formed regulatory 
topology at PE loci. Furthermore, neither short-range interactions with other 
flanking genes nor long-range interactions with more distally located genes 
were observed in mESCs or AntNPCs, as it is shown by the lack of contacts 
in these regions (Figure 4.10). 
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Figure 4.10 Poised enhancers already contact their target genes in mESCs. 4C-
seq and H3K27ac ChIP-seq profiles created in mESCs and AntNPCs are shown 
around PE Lhx5 (-109) (A), PE Six3 (-133) (B), PE Sox1 (+35) (C), and PE Lmx1b 
(+59) (D). PEs are shaded in green while their putative target genes are in yellow. 
PEs. Were used as viewpoints (red triangules) in all 4C-seq experiments. 
 
 
4.5- PEs are essential for the proper induction of major 
anterior neural genes 
 
In order to determine whether or not PEs are important for proper induction of 
their putative target genes, we decided to create PE deletions in mESCs 
using CRISPR-Cas9 (see introduction 1.1.2 and methods 3.6). Briefly, two 
gRNAs flanking the PE candidates were generated in order to recruit the 
Cas9 nuclease and generate double-stranded DNA breaks at these locations. 
Subsequently, these DNA breaks can be repaired by non-homologous end-
joining repair (NHEJ), which can frequently lead to deletion of the intervening 
DNA sequences (i.e the PE candidate). mESCs were  co-transfected with 
vectors co-expresing Cas9 and the pair of gRNAs flanking each PE 
candidate. Afer 48 hours of drug selection with puromycin, mESCs were 
seeded at clonal density, expanded and genotyped by PCR in order to identify 
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mESCs clonal lines with the desired PE deletions (Figure 4.11). At least one 
mESC clonal line with a homozygous deletion (PE -/-) of each PE candidate 
was obtained, with the exception of PE Lmx1b, which was no longer 
investigated. Moreover, a second mESC clonal line with a homozygous PE 
deletion was obtained for PE Lhx5 (-109), PE Sox1 (+ 35), PE Sox 21 (+6,5)). 
For PE Six3 (-133) and Wnt8b (+21) an additional line with a heterozygous 
PE deletion (PE +/-) was generated (Table 4.2). 
 
 
 
 
 
 
 
 
Figure 4.11: Strategy followed to delete PE regions by CRISPR-Cas9 
 
 
 
Table 4.2: List of generated mESC lines with PE deletions. 
 
 
 
In order to confirm that the selected mESC clonal lines carried the intended 
PE deletions, PCRs-based genotyping was used followed by Sanger 
sequencing (Figure 4.12, see methods 3.9.4). The PE Lhx5 (-109) and PE 
Wnt8b (+21) deletions were small in size (< 2000bp) and a single pair of 
primers could be used to detect both the WT and the deletion alleles (Figure 
4.12A). On the other hand, the PE Six3 (-133), PE Sox1 (+35) and PE Sox21 
PE identification Deletion Size 
(Kbp) 
Homozygous 
clones 
Heterozygous 
clones 
PE Lhx5 (-109) 0.5 2 0 
PE Six3 (-133) 5.2 1 1 
PE Sox1 (+35) 5.5 2 0 
PE Wnt8b (+21) 1.2 1 1 
PE Sox 21 (+6.5) 1.4 2 0 
Poised Enh
gRNA#1 gRNA#2
Poised Enh-/-
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(+6,5) deletions were larger and two different primer pair combinations were 
used to genotype the corresponding mESC clonal lines (Figure 4.12B). 
Figure 4.12: Genotyping 
of mESC clonal lines with 
PE deletions: (A) For PE 
Lhx5 (-109) and PE Wnt8b 
(+21), primer pairs flanking 
the deleted regions were 
used. For PE Lhx5 (-109), 
the PCR results show two 
mESC lines with 
homozygous PE deletions 
(-/-). For PE Wnt8b (+21), 
two mESC lines with an 
homozygous (-/-) or 
heterozygous(+/-) deletion 
of the PE are shown. (B) 
Two sets of primer pairs 
were used (1+2, 1+3) to 
genotype mESC lines with 
deletions for for PE Six3 (-
133), PE Sox1 (+35) and 
PE Sox21 (+6.5). 
Depending on the primer 
combinations used, DNA 
products specific to 
sequences that were either 
WT (1+3) or contained PE 
deletions (1+2) were 
amplified. For PE Sox1 
(+35) and PE Sox21 (+6.5), 
the PCR results obtained 
for two mESC lines with 
homozygous PE deletions 
(-/-) are shown. For PE 
Six3 (-133), two mESC 
lines with a homozygous (-
/-) or heterozygous (+/-) 
deletion of the PE are 
shown. * indicates 
unspecific PCR products. 
 
Afterwards, all the mESC lines with validated PE deletions were differentiated 
into AnNPCs and the expression of their target genes was evaluated by RT-
qPCR and compared to wild type (WT) parental cells (Figure 4.13). In 
undifferentiated mESC the expression of the PEs target genes was low and 
almost the same in wild-type mESCs and mESC lines with PE deletions 
(Figure 4.13). Importantly, these results indicate that PEs are not necessary to 
keep the expression of their target genes in an inactive state and, therefore, 
B
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they do not act as a silencers in mESCs as it has been previously proposed 
(Bonn et al. 2012; Entrevan et al. 2016; Spitz and Furlong 2012; Kondo et al. 
2014). In contrast, a major decrease in the expression of the PE target genes 
was observed upon differentiation of the mESC with PE deletions into 
AntNPC (Figure 4.13). For the mESC lines with, homozygous PE deletions, 
96% reduced induction for Lhx5, 84% for Sox1, 78% for Six3, 91% for Wnt8b 
and 27% for Sox21 was observed with respect to their parental WT cells 
(Figure 4.13F, G, H, I and J). For each PE-/- mESC line, the expression of its 
target gene was measured in at least two independent AntNPC 
differentiations and it was compared with WT AntNPCs differentiated in 
parallel. As an additional validation of the previous results, a second PE -/- 
mESC clonal line was also differentiated into AntNPC, which confirmed the 
strong effects of the PE deletions on the induction of their target genes 
(Figure 4.13).  For those PEs for which we could not generate a second 
mESC line with an homozygous deletion (i.e PE Wnt8b (+25) and PE Six3 (-
133)), we used mESC lines with heterozygous PE deletions instead. Upon 
AntNPC differentiation, these PE +/- mESC lines showed reduced expression 
of their target genes by roughly 50% compared to WT cells (44% reduction for 
Wnt8b and 52% of reduction for Six3 in PE Wnt8b (+25)+/- and PE Six3 (-
133)+/- respectively) (Figure 4.13 G and J). 
 
To corroborate that the effects of the PE deletions on the expression of their 
target genes were not due to general differentiation defects, the expression of 
Zfp42, a pluripotency gene was always evaluated in WT and PE-/- cells. 
Downregulation of Zfp42, was continuously observed upon differentiation of 
both WT and PE-/- mESCS, proving that the decreased induction of the PE 
target genes was caused to the specific PE deletions (Figure 4.13 F, G, H, I 
and J). 
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Figure 4.13: PEs are necessary for the induction of their target genes. (A, B, C, 
D and E) Genome browser captures of p300, H3K27me3, and H3K27ac ChIP-seq 
profiles in mESCs and of H3K27ac in AntNPCs are shown around PE Lhx5 (-109) 
(A), PE Six3 (-133) (B), PE Sox21 (+6,5) (C), PE Sox1 (+35) (D), and PE Wnt8b 
(+21) (E). The deleted regions are shaded in green. (F, G, H, I and J) The 
expression of the putative PE target genes (Lhx5 in F Six3 in G, Sox21 in H, Sox1 in 
I and Wnt8b in J). and of the Zfp42 pluripotency marker was measured by qRT-PCR 
in mESCs and AntNPCs that were either WT (blue), homozygous or heterozygous 
for a deletion of the indicated PEs. For each panel and from left to right, the first two 
graphs show the results obtained using mESC lines with PE homozygous deletions 
in two biologically independent differentiation experiments (Rep1 and Rep2). The last 
two graphs show the results obtained with a second mESC line for each PE 
candidate and that contained either homozygous PE Lhx5 (-109) (F), PE Sox21 
(+6,5) (H) and PE Sox1 (+35) (I) or heterozygous PE Six3 (-133) (G) and PE Wnt8b 
(+21) (J) PE deletions. The values of expression were normalized to two 
housekeeping genes (Eef1a1 and Tbp), and standard deviations (SDs) from 
technical triplicates are represented as error bars.  
 
The previously presented 4C-seq results in AntNPC and mESC (Figure 4.10) 
showed that PEs preferentially contacted nearby major anterior neural genes, 
suggesting that other genes were not likely to be directly controlled by these 
regulator elements. To demonstrate that PEs preferentially controlled the 
expression of the nearest anterior neural genes, the expression of three 
additional genes located around each PE was also evaluated by RT-qPCR. In 
general, the expression levels of these additional PE adjacent genes were not 
consistently and/or markedly affected by the PE deletion (Figure 4.14). 
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Figure 4.14: PEs neighboring genes are not affected by PEs deletions. The 
expression of three additional neighboring genes for PE Sox1 (+35), (A) PE Six3 (-
133), (B) PE Wnt8b (+21) (C) and PE Sox21 (+6.5) (D), was measured by RT-qPCR. 
For each gene, the results obtained using WT mESC and mESC lines with PE 
homozygous deletions in two biologically independent differentiation experiments 
(Rep1 and Rep2) are shown. Expression values were normalized to two 
housekeeping genes (Eef1a1 and Tbp) and the error bars represent standard 
deviations from technical triplicates.  
 
Overall, the previous experiments demonstrated that PEs are critical 
regulatory elements necessary for the proper induction of genes with major 
roles during the establishment of anterior neural identity.  
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4.5.1- Additional functional characterization of PE Lhx5 (-109) 
 
PEs are required for the induction of major anterior neural gene regulators but 
still it is not clear how. In order to gain more insights into this question, one of 
the PE candidates, PE Lhx5 (-109) was more extensively characterized. LHX5 
is an important transcription factor during forebrain development. In mice, this 
protein is essential for the regulation of precursor cell proliferation and the 
control of neuronal differentiation and migration during hippocampal 
development (Andrews et al. 2003; Y. Zhao et al. 1999). This protein is also 
involved in learning and motor functions in adult mice.  
 
As shown above (Figure 4.13F), the PE Lhx5 (-109) deletion leads to a 96 % 
decrease in the expression of Lhx5 in AntNPCs. To test whether a similar 
effect was observed at the protein level, immunofluorescence and western 
blot experiments were performed in mESC and AntNPCs that were either WT 
or homozygous for the PE deletions. Both experimental approaches 
confirmed that the PE Lhx5 (-109) deletion caused a dramatic reduction of 
LHX5 protein levels in AntNPCs. LHX5 western blot band was almost absent 
in PE Lhx5 (-109) -/- AntNPCs compared with WT AntNPCs (Figure 4.15A). 
Similarly, the LHX5 immunofluorescence staining levels for PE Lhx5 (-109)-/- 
AntNPCs were very low, almost compared with the levels in mESCs where 
LHX5 is not expressed (Figure 4.15B). 
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Figure 4.15: PEs Lhx5 (-109) deletion reduces LHX5 protein levels. (A) Western 
blot for LHX5 and TUBULIN as a loading control were performed in mESCs and 
AntNPCs for WT and PE Lhx5 (-109)-/- cells. The deletion induces a considerably lost 
in LHX5 levels in AntNPCs. (B) Immunofluorescence images in mESCs and 
AntNPCs where LHX5 protein levels were investigated in WT (top) or homozygous 
for a deletion of the PE Lhx5 (-109) (bottom). White bar represents 20 µm scale bar. 
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Afterwards, RNA-seq experiments were performed in AntNPCs derived from 
either WT or PE Lhx5 (-109)-/- mESCs to detect gene expression differences 
caused by the PE deletion. As expected, Lhx5 was the most significantly 
down regulated gene in PE Lhx5 (-109)-/- AntNPCs (Figure 4.16A). 
Interestingly, we observed that 376 additional genes were differentially 
expressed between WT and PE Lhx5 (-109) -/- AntNPCs. Among them, 228 
genes became up regulated and 148 genes were down regulated (Figure 
4.16B). Transcriptions factors involved in the development of the brain were 
particulary abundant amongst the downregulated set of genes, (Figure 
4.16B). We found Fezf2, which promotes neural differentiation during 
forebrain development (Zhang et al. 2014), Pax6, which regulates 
specification of the ventral neuron subtypes by establishing the correct 
progenitor domain (Takahashi and Osumi 2002) and Dlx2, which regulates 
differentiation of dopaminergic neurons of the ventral thalamus (Andrews et 
al. 2003) among the downregulated genes. On the other hand, the genes that 
resulted upregulated seemed to have a role in the neural repairing pathways. 
For instance, we found WNT signaling genes like Wnt4 and Wnt9 as well as 
genes involved in the regulation of calcium levels and synaptic plasticity. As 
examples, Gper1 which induces protection against oxygen glucose 
deprivation in hippocampal neurons (T.-Z. Zhao et al. 2016) or Grin2a, which 
has important roles in synaptogenesis and synaptic plasticity (Marwick et al. 
2015). A particularly interesting gene was Nnat, which was highly upregulated 
in PE Lhx5 (-109)-/- AntNPCs. Neuronactin, the protein encoded by Nnat, 
participates in the maintenance of the hindbrain segment identity in during 
development, and it is involved in the maintenance of the overall structure of 
the nervous system. It has also been reported that high levels of Neuronactin 
in neurons can produce pathological consequences, as observed in Lafora 
disease (Sharma et al. 2013). It is worth mentioning, that the previous RNA-
seq expression data revealed that the expression of the Lhx5 neighboring 
genes was not affected by the PE Lhx5 (-109) deletion (Figure 4.16C), which 
was in agreement with previous RT-qPCR experiments performed in ther 
other PE knockout lines (Figure 4.14). Finally a functional annotation of the 
genes significantly downregulated in PE Lhx5 (-109)-/- mESCs was performed, 
giving as a result an overrepresentation of genes involved in neuronal 
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differentiation and forebrain development (Figure 4.16D). Taken together, this 
data further validates that PEs are necessary for the proper induction of their 
target genes. Since these genes include major anterior neural regulators, PEs 
can be considered as more generally required for the establishment of 
anterior neural identity. 
 
Figure 4.16: Functional characterization of PE Lhx5 (-109) during AntNPC 
differentiation. (A) Lhx5 expression levels (as FPKMs) were measured by RNA-seq 
in WT AntNPC and Ant NPCs derived from two different PE Lhx5 (-109)-/- mESC 
clonal lines (Clon 1 and Clon2) (B) Plot representing RNA-seq data generated in WT 
AntNPCs or PE Lhx5 (-109)-/- AntNPC. Mouse genes were plotted according to the 
average normalized RNA-seq read counts in WT AntNPCs and PE Lhx5 (-109)-/- 
AntNPCs. Genes considered as significantly up-or down regulated in PE Lhx5 (-109)-
/- AntNPCs are shown in red and blue respectively. (C) Expression levels generated 
by RNA-seq as FPKMs in WT AntNPC and PE Lhx5 (-109)-/- AntNPC are shown for 
genes located immediately downstream (Dws) or upstream (Ups) of Lhx5, which is 
shaded in green. Error bars represent standard deviations from four independent 
biological replicates. (D) Functional annotation according to Gene Ontology 
Biological Process terms was performed for genes significantly downregulated in PE 
Lhx5 (-109)-/- AntNPCs. Ten out of the 20 most significantly overrepresented terms 
are shown. 
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4.5.2- PEs control the expression of lncRNAs divergently transcribed 
from the promoters of major anterior neural genes 
 
During the evaluation of the previous RNA-seq data, it was observed that one 
of the most down-regulated genes in AntNPCs originated from PE Lhx5 (-109) 
mESCs knock out lines was RP24-351J24.2 (Figure 4.17A).  This is a long 
non-coding RNA (lncRNA) divergently transcribed from the same promoter as 
Lhx5. Divergent lncRNAS were recently reported to facilitate the expression of 
essential developmental genes in cis due to the fact that they are in close 
proximity to them (S. Luo et al. 2016).  
 
Another two PEs, PE Six3 (-133) and PE Sox21 (+6.5), also presented 
divergent lncRNAs at their target promoters. As in the case of RP24-
351J24.2, the expression of these lncRNAs (i.e Six3os1 and AK 039417), 
measured by qPCR, was also reduced in the AnNPCs derived from mESC 
lines with deletions of the corresponding PEs (Figure 4.17 B and C). These 
results suggest that PE-dependent induction of major anterior neural genes 
might also entail divergent lncRNAs (S. Luo et al. 2016). 
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Figure 4.17:  PEs also regulate the expression of divergent lncRNAS. (A) RNA-
seq data obtained in AntNPC derived from WT mESC (four biological replicates) or 
from mESC with homozygous deletions of the PE Lhx5 (-109) is shown for Lhx5 and 
RP24-351J24.2. (B and C) Gene expression values were measured by RT-qPCR 
of Six3 (Six3os1) (B) and Sox21 (AK 039417) (C) lncRNAS in mESCs and AntNPCs 
that were either WT or homozygous for the indicated PE deletions.  
 
4.6- PEs control the induction of anterior neural genes in a 
non-redundant manner involving the recruitment of RNA PolII 
to promoter regions 
 
4.6.1- PEs are non redundant regulatory elements 
 
Results presented in this study demonstrated that PEs regulate the 
expression of their target genes upon anterior neural differentiation. We have 
also uncovered that the target genes of PEs are usually anterior neural 
master regulators. Similarly to other major cell identity genes, PE target genes 
frequently displayed complex regulatory landscapes in AntNPCs, as illustrated 
by the presence of multiple H3K27ac peaks representing putative active 
enhancers in these cells and that can potentially contribute to the expression 
of these genes. To further illustrate this regulatory complexity, several PE 
candidates were part of broader super-enhancer (SE) identified in AntNPCs 
using H3K27ac ChIP-seq data (Cruz-Molina et al. 2017; Heinz et al. 2015) 
(e.g PE Six 3(-133), PE Lhx5 (-109) and PE Sox1 (+35)) (Figure 4.18). 
 
Super-enhancers (SEs) differ from typical enhancers in content, TFs density, 
ability to activate transcription, topology and especially in size. SEs are 
clusters of enhancers densely occupied by major cell identity genes and 
mediator proteins. In principle, this regulatory complexity could confer gene 
expression robustness and the multiple enhancers controlling the same target 
genes could be redundant (Whyte et al. 2013; Shin et al. 2016).  However, our 
results showed that, despite this complexity the deletion of a single PE has 
dramatic consequences in the expression of its target gene. This indicates 
that an enhancer hierarchy might regulate the induction of major anterior 
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neural genes with PEs being the most important and non-redundant elements 
of this system.  
 
Figure 4.18:  PEs can be found within larger AntNPCs super-enhancers. (A-E) 
Vertebrate conservation (as phastcons) and ChIP-seq profiles for p300, H3K27me3 
and H3K27ac in mESCs as well as for H3K27ac in AntNPC are represented as 
genome browser pictures around five PE candidate regions. The engineered PE 
deletions are disguised in green. For three PE candidates, PE Lhx5 (-109) (A), PE 
Six3 (-133) (B) and PE Sox1 (+35) (C), the PEs were located within larger SEs 
identified in AntNPC based on the H3K27ac ChIP-seq signal (red rectangle).  
 
In order to investigate whether the induction of PE target genes is regulated in 
a hierarchical manner with PE playing an essential and non-redundant 
function, we examined how the deletion of individual PEs (PE Lhx5 (-109), PE 
Six3 (-133)) affected the activation, measured as gain of H3K27ac, of their 
target promoters as well as other enhancers located within the PE loci and 
presumably controlling the same genes in AntNPCs (Figure 4.19). ChIPs for 
H3K27ac were performed in mESCs and AntNPCs that were either WT or 
contained PE homozygous deletions (PE Lhx5 (-109)-/-, PE Six3 (-133)-/-) and 
H3K27ac levels were investigated by qPCR around the PE candidates, the 
corresponding PE target gene promoters and other putative enhancers 
located within the same regulatory domain. As expected, the deletions of the 
PEs lead to a loss in H3K27ac in AntNPCs around the deleted area and at the 
PE target gene promoters, which was in perfect agreement with the defective 
induction of PE target genes in AntNPCs. Most interestingly, PE deletions 
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also reduced H3K27ac levels in AntNPCs around the additional putative 
enhancers analyzed within each PE locus (Figure 4.19 B and C).  
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Figure 4.19:  PEs are non redundant regulatory elements during the induction 
of major anterior neural genes. (A), Representation of the design of the ChIP-q-
PCR primers used to detect H3K27ac levels around the deleted PEs. Genome 
browser representation of the Lhx5 (B) and Six3 (C) loci. PEs deletions are covered 
in green and additional putative enhancers as well as the PE target gene promoters 
are shaded in yellow. On the bottom, ChIP-qPCR graphics show the levels of 
H3K27ac in the selected areas for mESCs and AnNPCs that were either WT (blue) 
or contained homozygous deletions of the corresponding PEs.  
 
4.6.2- PEs facilitate the recruitment of the RNA pol II complex to the 
promoters of their target genes  
 
It has been reported, that in order to control the expression of their target 
genes during differentiation, enhancers can act at different steps of the 
transcriptional cycle, including the recruitment of the PolII pre-initiation 
complex (PIC) to the promoter regions of their target genes or facilitating the 
transcriptional initiation or elongation (Vernimmen and Bickmore 2015). To 
investigate at which of these steps PEs might preferentially act, we used 
ChIP-qPCR to measure the levels of pre-initiating (unphosphorylated PolII, 
8WG16) and initiating (Ser5 phosphorylated PolII) PolII at PEs and their target 
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gene promoters during AntNPC differentiation. As a control, we also analyzed 
the promoter region of a pluripotency gene, Zfp42, where the two PolII 
variants were expected to be bound in mESCs but not in AntNPCs (Figure 
4.20). 
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Figure 4.20:  PEs mediate the recruitment of the PolII pre-initiation complex to 
the promoters of their target genes. (A), ChIP-qPCR was performed to investigate 
the levels of pre-initiating (PolII 8WG16) (A, C, E and G) and initiating (PolII S5p) (B, 
D, F and H) PolII in mESCs and AntNPCs that were either WT (blue) or homozygous 
for four different PE deletions. For each PE candidate, PE Lxh5 (-109) (A and B), PE 
Six3 (-133) (C and D), PE Wnt8b (+21) (E and F) and PE Sox1 (+35) (G and H) PolII 
levels were measured around the deleted PE (Figure 4.20A), the corresponding PE 
target gene promoter and the Zfp42 promoter that was used as a control and should 
be not significantly affected by the PE deletions. ChIP-qPCRs were performed as 
technical triplicates and standard deviations are represented as error bars. 
 
The results of these experiments showed that PE deletions caused a strong 
reduction in the levels of pre-initiating PolII that were detected at the PEs and 
the PE target gene promoters upon AntNPC differentiation. We also observed 
similar reductions, although lower in magnitude, for the initiating PolII. In 
conclusion, PEs seem to preferentially control the induction of their target 
genes by mediating the recruitment of the pre-initiating PolII PIC to the 
promoter regions.  
 
4.7- PRC2 as topological facilitator of PEs regulatory activity. 
 
4.7.1- PEs-target gene contacts are PRC2 dependent 
 
In our previous 4C-seq experiments we uncovered that PEs were already 
contacting their target promoters in mESCs. These pre-formed contacts might 
facilitate robust and timely gene induction during differentiation and thus 
support the previously proposed poised enhancer state (Rada-Iglesias et al. 
2011) (Figure 4.10). It is worth mentioning that when 4C-seq profiles were 
evaluated in mESCs, the interaction signals of the PEs with their target genes 
mirrored the distribution of H3K27me3 around those genes. Since the 
Polycomb complex, and particularly its PRC2 subunit, mediates the deposition 
of H3K27me3 (Di Croce and Helin 2013), we proposed that such PE-target 
gene interaction could be PRC2 dependent. In order to corroborate this idea, 
we used mESC lines null for EED, a major PCR2 subunit, and thus defective 
for PRC2 activity. Then we performed 4C-seq experiments in EED-/- mESCs 
with the same PEs viewpoints that we used in WT mESCs. We found that in 
EED-/- lines the interactions between the PEs and their target genes were 
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dramatically reduced compared to WT mESCs at all four investigated loci 
(Figure 4.21A-D). In order to quantify the 4C signals, two intervals were 
created (R1 and R2) and contacts were analyzed (Cruz-Molina et al. 2017) 
(Figure 4.21E). R1 and R2 are 20Kb windows. R1 is centered on the 
transcription start site (TSS) of each PE target gene and R2 is located in an 
intermediary position between PE and target gene. The quantification gave as 
a result a significative difference in the 4C-signal in the target gene area (R1) 
while this tendency was not observed for the area not occupied by PRC2 
(R2). Therefore, we concluded that PRC2 is necessary for the formation of the 
PEs – target gene contacts in mESCs. 
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Figure 4.21: Contacts between PEs and their target genes in mESCs are PRC2 
dependent. 4C-seq profiles generated in WT and EED-/- mESCs as well as 
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H3K27me3 ChIP-seq profiles generated in WT mESCs are shown around PE Lhx5 (-
109) (A), PE Six3 (-133) (B), PE Sox1 (+35) (C), and PE Lmx1b (+59) (D). The 
H3K27me3-marked regions that cover the PEs target genes are shaded in yellow 
and the PEs in green. The red triangles represent the 4C-seq viewpoints. (E) For 
each locus showing in (A-D), 4C signals were quantified in two regions R1 and R2, 
where R1 is a 20 Kb window centered on the transcription start site (TSS) of each PE 
target gene and R2 is another 20 Kb window located in an intermediate position 
between each PE and its corresponding target gene. P-values were obtained by 
using Wilxon tests. 
  
 
To validate the previous results, 3C-PCR experiments were performed using 
4C and 3C libraries generated in WT and EED-/- mESCs as templates. In 
these experiments, specific primers are used to amplify chimeric DNA 
fragments representing PE-target gene interactions (see methods 4.7.3, 
4.9.6). The outcome of these experiments confirmed our previous results, as 
PCR products were either absent or considerably weaker in EED-/- mESCs 
compared to WT mESCs, therefore PRC2 is needed to create this interaction 
(Figure 4.22). 
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Figure 4.22: PCR validation of the PE-target gene contacts. 3C and 4C libraries 
generated for WT and EED-/- mESCs lines were analyzed by PCR using primers 
placed in the PE and the target promoter locus of each PE candidate studied. The 
Tbp amplicon was used as a positive control and a pair of primers located at Sox1 
PE and Six3 promoter respectively, two regions that according to 4C-seq 
experiments were not predicted to physically interact, were combined and used as a 
negative control.  
 
In the literature, it has been previously reported that enhancer-gene 
interactions are frequently mediated by architectural proteins, such as CTCF, 
Mediator or Cohesin (Kagey et al. 2010; Phillips-Cremins et al. 2013). To 
determine whether these architectural proteins also contribute to PE-target 
gene interactions in mESCs, we compare our mESC PEs with publically 
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available ChIP-seq data generated in mESCs for these proteins (Kagey et al. 
2010; Cruz-Molina et al. 2017). These comparisons showed that only a small 
fraction of our PEs and none of the PEs investigated by 4C-seq were 
occupied by these architectural proteins (Figure 4.23A). On the other hand, it 
has been recently described that PcG bound genes can engage into long-
range interactions (trans or inter-TAD interactions) in mESC and such 
interactions are mediated by PRC1 and PRC2. Moreover, these long-range 
interactions are particularly prominent at the four Hox genes clusters 
(Denholtz et al. 2013; Joshi et al. 2015; Schoenfelder et al. 2015). However, 
very limited long-range interactions in mESC were showed in our 4C-seq 
experiments, which were centered on PEs, our data showed that most 
interactions occurred in cis (intra-TAD) (Figure 4.23B).  
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Figure 4.23: PRC2 is the main protein responsible of mediating contacts 
between PE and their target genes. (A). Percentage of PEs in mESCs overlapping 
CTCF, Mediator (MED1 and MED12) and Cohesin subunits (SMC1 and SMC3). (B) 
WT and EED-/- mESC 4C-seq profiles generated at the HoxA gene locus for four 
different PEs as viewpoints (from bottom to top: PE Lmx1b (+59), PE Sox1 (+35), PE 
Six3 (-133) and PE Lhx5 (-109)).  
 
4.7.2- Poised enhancer regulatory activity is facilitated by PRC2  
The presence of H3K27me3 is one of the defining features of ESC PEs. This 
histone mark is deposited by PRC2 and it has been usually considered to be 
associated with transcriptional repression. Consequently, it was previously 
proposed that the presence of H3K27me3 and PRC2 at PEs could prevent 
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the spontaneous activation of these elements in absence of the relevant 
activating signals (Bonn et al. 2012; Spitz and Furlong 2012). However, our 
previous results have convincingly demonstrated that PRC2 enables the 
physical interaction between PEs an their target genes in mESCs, thus 
potentially creating a permissive regulatory topology that could facilitate the 
induction of the PE target genes during AntNPCs differentiation. In agreement 
with this hypothesis, recent studies reported that PRC2 is not required for 
transcriptional repression in mESCs (Riising et al. 2014) indicating that PRC2 
is not necessary for maintaining PEs in an inactive state and also that the role 
of PRC2 in pluripotent cells might be different from what was previously 
anticipated.  
 
To start evaluating whether PRC2 could facilitate PEs’ regulatory activity, we 
performed H3K27me3 and H3K27ac ChIP-seq experiments in EED-/- mESCs 
as well as in AntNPCs generated from the EED-/- lines. As it was previously 
described (Leeb et al. 2010; Schoeftner et al. 2006), we observed that the lost 
of PRC2 lead to an almost total absence of H3K27me3 in EED-/- mESCs 
globally around PEs and around PoiAct enhancers (Figure 4.24A, B and D). 
However, no enrichment in H3K27ac around PEs was observed, especially 
compared with the H3K27ac levels at PoiAct regions in WT AntNPCS (Figure 
4.24A, C and E). If PRC2 was indeed needed for maintaining PEs in an 
inactive state, we should have observed an increase in H3K27ac in the EED-/- 
lines. Since that was not the case, these results further suggest that PRC2 is 
not acting as a repressor in the context of PEs.  
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Figure 4.24: PRC2 is not necessary to maintain PEs in an inactive state. (A). 
Genome browser representation around PE Lhx5 (-109) locus of H3K27me3 and 
H3K27ac ChIP-seq profiles generated in WT and EED-/- mESCs as well as H3K27ac 
ChIP-seq profiles in WT and EED-/- AntNPCs. (B and C) Average H3K27me3 (B) and 
H3K27ac (C) ChIP-seq signals in WT and EED-/- mESC around all mESCs PEs. (D 
and E) Average H3K27me3 (D) and H3K27ac (E) ChIP-seq profiles around PoiAct 
enhancers are shown for WT and EED-/- mESCs as well as WT and EED-/- AntNPCs. 
 
We then asked how the loss of PRC2 activity could affect the expression of 
the PE target genes during AntNPC differentiation. Therefore, we generated 
RNA-seq profiles for EED-/- mESCs and AntNPCs and compared them with 
similar expression profiles previously generated in WT cells. In agreement 
with the minimal activation of PEs in EED-/- mESCs, the expression of the 
genes linked to PEs was barely increased in EED-/- mESCs compared with 
WT mESCs. Moreover and in concordance with previous reports, pluripotency 
genes remained highly expressed in EED-/- mESCs, while the expression of 
other non neural somatic markers like Gata4 and Sox17 showed a more 
evident de-repression (Leeb et al. 2010). Most interestingly, upon 
differentiation into AntNPCs, major anterior neural genes linked to PEs (e.g. 
Lhx5, Six3, Fezf2) were induced at considerably lower levels in EED-/- 
AntNPCs compared with WT AntNPCs (Figure 4.25 A-B). In contrast, when 
genes induced during the differentiation of mESCs into AntNPCs but not 
Results  
	   101	  
linked to PEs were considered (indAll), the expression differences between 
WT and EED-/- AntNPCs were minimal (Figure 4.25C-D). These results 
indicate that the defective induction of neural genes upon differentiation of 
EED-/- mESCs seems to be specific to anterior neural genes linked to PEs.  
Consequently, our results indicate that, in mESCs, PRC2 might facilitate the 
future activation of major anterior neural identity genes.  
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Figure 4.25: PRC2 as facilitator of the induction of anterior neural genes. (A) 
Gene expression was measured by RNA-seq in WT and EED-/- mESCs and 
AntNPCs. Expression levels (as FPKMs) are shown for pluripotency, mesodermal, 
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endodermal and posterior neural gene markers as well as for genes linked to PoiAct 
enhancers. (B) RNA-seq data from WT and EED-/- mESCs as well as their AntNPCs, 
were used to calculate the expression levels of all mouse genes (All), genes linked to 
PEs (Poised), genes linked to PoiAct enhancers (PoiAct), and genes linked to PoiAct 
enhancers that were induced ≥2-fold in WT AntNPCs compared to WT ESCs 
(indPoiAct). (C) RNA-seq data from WT mESC, WT AntNPC, EED -/- mESCs and 
EED -/- AntNPCs were used to calculate the expression levels of All genes, indPoiAct 
genes, all genes induced ≥2-fold in WT AntNPC compared to WT ESC after 
excluding indPoiAct genes (indAll) and genes whose promoters are marked by 
H3K27me3 in mESC according to (Bernstein et al. 2006) (H3K27me3). (D) Fold-
change expression differences between WT AntNPCs and EED-/- AntNPCs are 
shown for indPoiAct genes, indAll genes, and H3K27me3 genes. P values for B, C 
and D were calculated using unpaired Wilcoxon tests. 
 
 
In order to validate our previous results and confirm that PRC2 can facilitate 
PEs regulatory activity we used mESCs null for Suz12, another PRC2 
subunit, which are also defective for PRC2 activity (Suz12 -/- mESCs). Suz12-/- 
and WT mESCs were differentiated into AntNPCs and the expression of some 
selected genes was measured by RT-qPCR. The results were very similar to 
the ones we obtained upon differentiation of EED-/- mESCs and major anterior 
neural genes linked to PEs failed to be induced in Suz12-/- mESCs (Figure 
4.26).  
 
Finally, to test whether PRC2 preferentially acts as a facilitator during the 
induction of genes involved in anterior neural development, we differentiated 
WT and EED-/- mESCs into mesodermal progenitors used a previously 
described protocol (see methods 3.3.5) as an example of a non-neural 
somatic lineage. Importantly, mesodermal markers were induced at normal or 
even higher levels in EED-/- mesodermal precursors than in their WT 
counterparts (Figure 4.27). Overall, together with recent observations in hESC 
(Collinson et al. 2016), our results suggest that, in agreement with the 
classical view of PcG complexes, PRC2 can act as a repressor of genes 
involved in mesodermal and endodermal development while playing a novel 
role as a facilitator  during the activation of major anterior neural genes. 
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Figure 4.26: Suz12-/- mESCs show an impaired induction of major anterior 
neural genes during AntNPCs differentiation, which resembles EED-/- mESCs 
expression profile.  RT-qPCRs were performed to measure gene expression in 
mESC and AntNPCs that were either WT (Blue) or Suz12-/- (green). Gene expression 
levels are shown for anterior neural genes linked to PEs (Lhx5, Fezf2, Pax6 and 
Six3), pluripotency markers (Zfp42) and mesodermal genes (T). Experiments were 
performed as two independent biological replicates (Rep1 and Rep2) and error bars 
represent the standard deviations of technical triplicates. Tbp and Eef1a were used 
as housekeeping genes. 
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Figure 4.27: PRC2 acts as a facilitator for the induction of anterior neural genes 
and as a repressor for mesodermal genes. The expression of anterior neural 
(Fezf2, Wnt8b, Lhx5), pluripotency (Zfp42) and mesodermal (T, Mixl1, Gsc) genes 
was evaluated by RT-qPCR in WT and EED-/- mESC upon AntNPCs or mesodermal 
(Mes) differentiation.  Experiments were performed as biological duplicates (Rep1 
and Rep2). Eef1a1 and Tbp were used as housekeeping genes to normalize the 
gene expression values and the standard deviations are represented as error bars 
from technical triplicates. 
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4.7.3- H3K27me3 deposition is enabled by the intrinsic genetic features 
of the poised enhancer regions. 
 
In this work, it has been intensively demonstrated that the contacts between 
PEs and target genes in mESCs are PRC2 dependent and also that these 
contacts seem to be necessary for the proper induction of major anterior 
neural gene regulators. These novel and relevant findings made us wonder 
how PRC2 is initially recruited to PEs. We considered two main possibilities:  
 
1- PEs recruit PRC2 in a direct manner and independently of their target 
gene promoters. 
2-  The presence of PRC2 at PEs is indirect and a consequence of the 
physical proximity to genes heavily bound by PRC2.  
 
In order to gain some initial insights into this question, we first used mESCs 
public ChIP-seq data (Livyatan et al. 2015; Ku et al. 2008) to confirm that 
PRC1 and PRC2, and not only H3K27me3 were significantly enriched in the 
PEs regions. We evaluated the presence of RING1, a subunit of PRC1 as well 
as EZH2 and Suz12, core components of PRC2 in two PE loci (PE Six3 (-
133) and PE Sox1 (+35)). As it was expected, PRC1 and PRC2 subunis were 
enriched in the PE loci as well as in their target genes (Figure 4.28A-B). In 
addition, proteins present in mESCs were ranking using the enrichment in the 
whole genome as a background showing a remarkably presence of the PcG 
subunits in mESCs (Figure 4.28C) (Chen et al. 2008). 
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Figure 4.28: PEs are bound by PRC1 and PRC2 in mESCs. (A-B) P300, 
H3K27me3, Ring1b, Ezh2 and Suz12 ChIP-seq signal profiles in mESC are shown 
around (A) PE Six3 (-133) and (B) PE Sox1 (+35). (C) Proteins investigated by ChIP-
seq in mESC were ranked according to their enrichment levels in mESCs with 
respect to the whole genome (used as background). The top 10 most and least 
enriched proteins are shown in red and blue, respectively. Enrichment analysis was 
performed using BindDB (Livyatan et al. 2015). PRC2 subunits: Ezh2, Jarid2, Ezh1, 
Suz12 and PHF19; PRC1 subunits: Ring1b.  
 
Afterwards, a differential motif analysis was performed between PEs and 
active enhancers in order to identify DNA sequences that could be potentially 
involved in the recruitment of PRC2 to PEs. These analyses revealed that the 
most overrepresented motifs in all PEs presented a high CpG dinucleotide 
content (Figure 4.29A). Accordingly, PEs displayed much higher CpG 
dinucleotide frequency than active enhancers and frequently overlapped or 
were close to CpG islands (Figure 4.29 B). Further analysis divided the CpG 
regions between “weak” and “strong” depending on the CG content and 
determined that 74% of our PEs were within a weak CpG island (Cruz-Molina 
et al. 2017) (Figure 4.29C). 
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Figure 4.29: PEs display a high CpG dinucleotide content and frequently 
overlap with CpG islands. (A) Identification of motifs significantly enriched in PEs 
defined in mESC with respect to active enhancers (Cruz-Molina et al. 2017; McLean 
et al. 2010). (B) CpG dinucleotide frequencies for active (purple) and poised (green) 
enhancers are shown from 1 kb upstream (-1 kb) to 1 kb downstream (+1 kb) of the 
enhancers’ mid position (C) Fraction of active (purple) and poised (green) enhancers 
overlapping classical (left) or weak (right) CpG islands. Statistical analysis (Cruz-
Molina et al. 2017). 
 
Several recent publications reported that CpG islands close to inactive gene 
promoters can act as a Polycomb response elements (PREs), that can 
directly recruit PcG complexes (Lynch et al. 2012; Mendenhall et al. 
2010).Therefore, the majority of our PEs are within or close to a CpG island, 
we hypothesize that the PEs are found within a genomic context with a 
sequence composition which can directly mediate the recruitment of PRC2.  
 
In order to evaluate this hypothesis, we used the mESC lines that we 
generated with homozygous deletions of different PE candidates. In two of 
those mESC lines, the PE deletions included a CpG island (PE Six3 (-133) 
and PE Sox1 (+35)), while for another two mESC lines they did not (PE 
Wnt8b (+21) and PE Lhx5 (-109)). Then, in these mESC lines we measured 
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H3K27me3 by ChIP-qPCR in the regions immediately flanking the PE 
deletions as readout of PRC2 binding. Remarkably, H3K27me3 was 
significantly lost only in the mESC lines in which the PE deletions within a 
CpG island (Figure 4.30 B and D), while that was not the case for the PE 
deletions non-overlapping a CpG island (Figure 4.30 A and C). Moreover, 
ChIP-seq experiments showed that this lost of H3K27me3 was not global but 
rather restricted to the regions flanking the deleted PEs (e.g. PE Sox1 (+35)). 
Therefore, PEs frequently reside in a genomic context with a high CpG 
dinucleotide content that can directly recruit PRC2 to these regulatory 
elements. We propose that the presence of PRC2 (and H3K27me3) at the 
PEs as well as at their target genes might lead to the physical contacts 
between both regions and therefore create a permissive regulatory topology, 
which facilitates the robust and timely induction of the anterior neural gene 
expression program during mESCs differentiation  
 
 
Figure 4.30: PEs overlapping a CpG island can act as PREs. (A-B) To investigate 
how the PE deletions affect H3K27me3 deposition; ChIP-qPCR primers were 
designed in close proximity to the deleted PE regions. H3K27me3 ChIPs were 
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performed in WT mESCs and mESCs with homozygous PE deletions in which the 
deletion did not include (A) or included (B) a CpG island. ChIP-qPCR signals were 
normalized using two different control regions (‘‘Chr6_neg’’ and ‘‘Sox2_prom’’). The 
error bars represent the standard deviations of six different ChIP-qPCR 
measurements (two ChIP biological replicate samples and three technical qPCR 
replicates for each sample). (C and D) H3K27me3 ChIP-seq profiles generated in 
WT, PE Sox1 (+35)-/- and PE Lhx5 (-109)-/-, mESCs are shown around PE Lhx5 (-
109) (not overlapping a CpG island) (C) and PE Sox1 (+35) (overlapping a CpG 
island). (D). Green rectangles represent CpG islands (CGI). 
 
 
4.8-. Identification of Zic2 as a potential activator of PEs 
during AntNPCs differentiation. 
 
The differential motif analysis between poised and active enhancers 
described above revealed that, in addition to CpG-dinucleotide rich motifs, the 
binding sites of the Zic TF family was also highly enriched among PEs (Figure 
4.31A). Zic TFs are evolutionary conserved regulators of neuroectodermal 
development, indeed they are involved in development of neural crest and 
another neural tissues, in somite development and in left-right axis patterning 
(Merzdorf 2007).  
 
In order to determine if this family of TFs could be involved in the activation of 
PEs upon AntNPCs differentiation, we first evaluated by RT-qPCR the gene 
expression profile of the three main Zic family members (Zic1, Zic2 and Zic3) 
during the differentiation of mESCs into AntNPCs. The expression pattern of 
Zic2 was particularly interesting, as it was already expressed in mESCs, 
became upregulated by differentiation day three and remained highly 
expressed at days five and seven (Figure 4.31B). On the other hand, Zic1 
was not expressed in mESCs and it was specifically induced at late stages of 
differentiation (Figure 4.31B). In contrast, Zic3 was highly expressed in 
mESCs and posteriorly down-regulated during AntNPCs differentiation, which 
is in agreement with Zic3 being required for maintaining pluripotency in 
mESCs (Lim et al. 2007) (Figure 4.31B). 
 
Afterwards an analysis of public ChIP-seq data for Zic2 and Zic3 in mESCs 
demonstrated that only Zic2 is frequently bound to PEs in general and to PEs 
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that become active in AntNPCs differentiation (i.e PoiAct enhancers) (Ishiguro 
et al. 2007; Z. Luo et al. 2015) (Figure 4.31C and D).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.31: Zic2 might be involved in the activation of PEs. (A) The analysis of 
Motif Enrichment (AME) software (McLeay and Bailey, 2010) was used to identify 
motifs significantly enriched in mESC PEs with respect to mESC active enhancers. 
The binding sites for Zic TFs were among the most overrepresented motifs in PEs. 
(B) RT-qPCR experiments showing the expression dynamics of Zic1, Zic2 and Zic3 
during the differentiation of mESC (D0) into AntNPCs (Days 3-7, D3-D7). (C) 
Genome browser view of ZIC3 and ZIC2 ChIP-seq profiles in mESC around PE Six3 
(-133). (D) Percentage of PEs and PoiAct enhancers bound by ZIC2 (dark blue) and 
ZIC3 (light blue) in mESC. 
 
Altogether, these preliminary observations suggest that ZIC2 might be 
involved in PEs activation and anterior neural induction. As more extensively 
described in the perspectives section, this possibility is now being 
experimentally tested. 
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5- DISCUSSION 
 
5.1- Poised enhancers are regulatory sequences associated 
with the pluripotent cellular state 
 
Poised enhancers were originally described in hESCs based on the 
simultaneous presence of activating (TFs, P300) and repressive (H3K27me3, 
PcG) features (M. P. Creyghton et al. 2010; Rada-Iglesias et al. 2011). As 
these enhancers were shown to become active upon somatic differentiation, 
they were proposed to reside in an inactive but poised state that could 
facilitate their timely and robust activation during ESCs differentiation (Rada-
Iglesias et al. 2011) (Figures 4.1, 4.4 and 4.9). However, alternative models 
were subsequently proposed, according to which the presence of H3K27me3 
at enhancer sequences indicated an inactive or repressive state that could 
negatively influence the expression of putative target genes (Bonn et al. 2012; 
Spitz and Furlong 2012). In these studies, the original definition of PEs was 
not followed and PEs were identified as genomic regions enriched in 
H3K4me1 and H3K27me3, without taking into account the presence of co-
activators (e.g. p300, CBP) and/or TFs. Nonetheless, the data presented in 
this thesis indicates that the presence of these TFs and regulatory proteins is 
an essential and distinctive component of PEs in pluripotent cells. In contrast 
to H3K4me1 (Bonn et al. 2012; Cheng et al. 2014; Koenecke et al. 2016) 
these proteins can truly represent activating features that bookmark PEs for 
future activation. As a matter of fact, our previous work demonstrated that, if 
the original chromatin signature is used, very few PEs are identified outside 
the pluripotent state, mostly due to the absence of co-activators or TF binding 
within a H3K27me3 chromatin environment (Rada-Iglesias et al. 2012). 
Although the molecular reasons behind the scarcity of PEs outside 
pluripotency remains unknown, it is possible that chromatin enriched in PcG in 
ESC displays unique features that make it more accessible to TFs and other 
regulatory proteins (Bernstein et al. 2006; Menno P. Creyghton et al. 2008; 
Meshorer et al. 2006). Interestingly, it was recently reported that PEs might be 
also common in neural crest cells in vivo (Minoux et al. 2017). Since similarly 
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to ESCs, neural crest cells also have broad differentiation potential, it is 
tempting to speculate that PEs might be found within particularly plastic stem 
cell populations.  
 
5.2- PEs are essential and non-redundant regulatory elements 
during the induction of major anterior genes 
 
The functional relevance of PEs was clasically supported by correlative 
observations like those provided by reporter assays (Rada-Iglesias et al. 
2011; Zentner et al. 2011). Using precise genetic deletions, our data shows 
that these cis-regulatory elements are necessary for the induction of their 
target genes upon mESCs differentiation. Moreover, PE deletions did not 
have as a consequence the de-repression of their target genes in mESCs, 
arguing against these sequences having silencer activity (Figure 4.13) 
(Entrevan et al. 2016; Kondo et al. 2014; Kondo et al. 2016).  
 
The target genes of PEs typically reside within complex regulatory landscapes 
in which multiple and somehow redundant enhancers are believed to confer 
transcriptional robustness and fidelity (Frankel et al. 2010; Whyte et al. 2013). 
Nevertheless, our results demonstrated that the deletion of single PEs was 
sufficient to dramatically compromise the induction of their cognate genes. In 
the same way, it was also demonstrated, that individual PE deletions lead to a 
lost of H3K27ac at other enhancers presumably controlling the same target 
genes. This indicates that PE deletions can lead to a general decrease in 
enhancer activity within the regulatory domains of the PE target genes (Figure 
4.19). Therefore, an enhancer hierarchy might exist during the induction of 
major anterior neural genes, with PEs playing a critical and non-redundant 
role. We hypothesize that other enhancers within these loci might be required 
for the maintenance and/or fine-tuning of gene expression patterns.  
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5.3- Poised enhancers as part of the “default” induction of 
anterior neural identity in ESC. 
 
The first decisive step of neural development, the neural induction, is 
commonly thought to result from a ‘default’ embryonic pathway. Traditional 
developmental models suggest that epiblast cells in vivo and ESCs in vitro are 
predetermined by “default” (i.e. without extrinsic signals) towards the neural 
lineage (Gaspard and Vanderhaeghen 2010; Levine and Brivanlou 2007).  
Moreover, this “default” model also proposes that, to form non-neural tissues 
like mesoderm or endoderm as well as more posterior neural tissues (e.g. 
spinal cord), the epiblast cells in vivo and the ESCs in vitro need to be 
exposed to instructive signals (e.g. WNT, BMP, RA) (Levine and Brivanlou 
2007; Stern 2005) 
 
However, there is a main open question, in this “default” model of neural 
induction, why do pluripotent cells show this preference towards the anterior 
neural fate? Our data shows that PEs are preferentially associated with major 
anterior neural gene regulators (e.g. Six3, Lhx5, Pax6, Sox1, Wnt8b, Fezf2, 
Pax2, Emx2) (Figure 4.10) and also have an essential function during their 
induction. Taken together, these results indicate that PEs could represent a 
novel and important component of the “neural default” model. We propose a 
model where genetic (TF binding sites, CpG richness) and epigenetic 
(H3K27me3, p300) features are involved. We suggest that PEs might confer 
to anterior neural loci with a permissive regulatory topology that gives cells 
competency for neural induction once pluripotency signals (i.e. BMP, WNT) 
disappear and neural induction signals (i.e. FGF) arise (de Laat and Duboule 
2013; Levine and Brivanlou 2007; Stern 2005). On the other hand, the master 
regulators of non-neural (i.e. mesoderm and endoderm) and posterior neural 
tissues, which are not as frequently linked with PEs, might be often found 
within another kind of regulatory domains in which enhancers and enhancer-
promoter contacts are established de novo in response to extrinsic signals (de 
Laat and Duboule 2013). 
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5.4- PcG proteins as mediators of short and long-range 
regulatory interactions 
 
4C-seq experiments revealed that in mESCs, PEs physically interact with their 
target genes in a PRC2 dependent manner. These findings are not in 
agreement with a recent study (Schoenfelder et al. 2015) where interactions 
were measured by using promoter capture Hi-C (CHi-C). In that study it was 
reported that long-range (inter-TAD) interactions between PcG bound 
promoters but not short-range (intra-TAD) interactions between PEs and their 
putative target genes were PRC1 dependent in mESCs. There could be 
several reasons for these discrepancies:  
 
1- In Schoenfelder et al. PEs were defined only by the presence of 
H3K4me1 and H3K27me3, without requiring the binding TF and/or co-
activators. Therefore, a broader set of genomic regions with potentially 
different regulatory and chromatin properties compared to our stringent 
set of PEs might have been considered. 
 
2- In Schoenfelder et al. the PRC1 dependency of the PE-promoter 
contacts was analyzed using an “all-or-nothing” approach, considering 
whether a contact was either maintained or lost. Nevertheless, it is 
plausible that loss of PRC1 or PRC2 might lead to a partial, rather than 
total, loss of contacts between PEs and their target genes, as our 4C-
seq data and the 3C and 4C validation experiments suggests (Figure 
4.10, 4.21 and 4.22). Lastly, some, but not all, of the PE-target gene 
contacts identified by Schoenfelder et al. were maintained in PRC1 null 
mESCs. 
 
 
3-  Schoenfelder et al. used a 6-bp cutter enzyme in their CHi-C 
experiments. This kind of enzymes have less spatial resolution than the 
double 4bp-cutter approach used in our 4C-seq experiments and, 
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consequently, they are less suitable to investigate short-range 
interactions like the ones established between PEs and target genes.  
 
It has been previously reported that in mESCs and Drosphila, PcG complexes 
may be involved in both short and long-range genomic interactions 
(Bantignies et al. 2011; Denholtz et al. 2013; Entrevan et al.2016; Joshi et al. 
2015; Lanzuolo et al. 2007; Schoenfelder et al. 2015). Such interactions are 
probably dependent on the biochemical compatibility between different 
PRC1/2 subunits and their associated histone modifications (H3K27me3, 
H2AK119ub) (Hansen et al. 2008; Kyoichi Isono et al. 2013). Notably, our 
data indicates that poised enhancers mostly establish local interactions with 
target genes located in the same TAD in contrast with the long-range inter-
TAD interactions between PcG bound genes that have been reported in 
several recent studies (Denholtz et al. 2013; Joshi et al. 2015; Splinter et al. 
2012; Vernimmen et al. 2007). Major developmental genes usually display 
higher and broader PRC1/2 and H3K27me3 occupancy than PEs. We 
speculate that this fact might offer a biochemical explanation for the capacity 
of developmental genes to engage into long-range inter-TAD interactions 
(Hansen et al. 2008; Kyoichi Isono et al. 2013).  
 
Overall, together with a number of recent reports, our data support a major 
role for PcG proteins in regulating genome architecture through a combination 
of long and short-range physical interactions (Entrevan et al. 2016).  
 
5.5- PcG complexes as facilitators of gene induction during mESC 
differentiation 
 
It has been previously shown that PRC2 null mESCs present differentiation 
defects due to insufficient silencing of pluripotency genes and unspecific de-
repression of somatic regulators, which is in full agreement with the general 
view of PcG proteins as major epigenetic repressors, (Boyer et al. 2006; Obier 
et al. 2015; Pasini et al. 2007). Therefore, it was proposed that, in the context 
of PEs, PcG proteins could prevent these regulatory elements from premature 
or spurious activation or even confer them with silencer activity (Di Croce and 
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Helin 2013; Entrevan et al. 2016; Kondo et al. 2016). However the results 
here shown demosntrated that loss of PRC2 activity and H3K27me3 depletion 
did not lead to the activation of PEs, as these regulatory sequences only 
marginally gained H3K27ac in EED knockout mESCs (Figure 4.24). 
Moreover, the deletion of PEs did not result in a significant de-repression of 
their target genes in EED-/- mESCs, arguing against the previously proposed 
silencer activity of these regulatory elements (Figure 4.25). Most interestingly, 
the differentiation of EED -/- mESCs towards AntNPC demonstrated that the 
loss of PRC2 heavily compromised, rather than increased, the induction of 
major anterior neural genes linked to PEs. Together with the PRC2-
dependent contacts that PEs and their target genes already establish in 
mESCs, these results made us propose a novel role for PcG-complexes in 
pluripotent cells, whereby PRC2 bestows major anterior neural loci with a 
permissive regulatory topology that makes them competent to become 
robustly activated once the appropriate differentiation cues become available 
(Figure 5.1).  
 
This model is in full agreement with recent reports demonstrating that PRC2 is 
not required for gene silencing in mESCs as well as with classical in vivo and 
in vitro studies in which PRC2 was shown to be necessary for somatic 
differentiation but not for the maintenance of pluripotency (Chamberlain, Yee, 
and Magnuson 2008; Faust et al. 1998; Leeb et al. 2010; Pasini et al. 2007; 
Riising et al. 2014). We postulate that the differentiation defects observed in 
PRC2 knockout mESC might involve a dual role of PcG proteins as epigenetic 
repressors of mesodermal and endodermal genes and topological facilitators 
of anterior neural genes (Figure 4.27).  
 
The role of PcG complexes as topological facilitators of gene induction has a 
single precedent in vertebrates (Kondo et al. 2014). According to this study, a 
PRC1-bound distal element located at the 3’ end of Meis2 acts as a silencer 
of this gene in most tissues during mouse embryogenesis. However, this 
same element facilitates the communication of Meis2 promoter with a 
hindbrain-specific enhancer and thus the following activation of Meis2 in the 
hindbrain. Interestingly, this PRC1-bound element is among the PEs we 
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identified in mESCs and, according to H3K27ac ChIP-seq data generated in 
mouse E11.5 forebrain (Nord et al. 2013), it represents an active enhancer in 
the forebrain, a tissue displaying high Meis2 expression (Kondo et al. 2014). 
Thus, we hypothesize that the PRC1-bound element described in by Kondo 
et. al represents a PE in pluripotent cells that becomes active in the forebrain 
while acting as a structural scaffold in the hindbrain and ultimately facilitating 
Meis2 induction in these two tissues.  
 
Finally, we also discovered that a significant fraction of PEs reside in a 
genomic context with high CpG content, which endows these regulatory 
elements with the innate capacity to recruit PcG-complexes (Lynch et al. 
2012; Mendenhall et al. 2010). These sequence features might allow PEs to 
remain marked by H3K27me3 and bound by PRC2 once pluripotent cells 
differentiate into non-anterior neural lineages. Since PRC2 repressive function 
is most apparent upon non neural differentiation (Riising et al. 2014), this 
might ensure that PEs do not become active in the wrong developmental and 
cellular contexts. 
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Figure 5.1: Proposed model for PEs function. In mESCs PEs are already 
contacting their target genes in a PRC2 dependent manner. We propose that these 
contacts create a permissive regulatory topology that upon appearance of the 
relevant differentiation cues and subsequent binding of TFs, co-activators, RNA PolII 
to the PEs, facilitates the induction of their congnate genes.
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6- PERSPECTIVES 
 
6.1- In vivo relevance of PEs. 
 
In this work, we have demonstrated the functional relevance of pluripotency-
associated PEs in vitro, however, their importance has not been evaluated in 
vivo yet, although preliminary observations in zebrafish embryos at least 
support their existence (Bogdanovic et al. 2012; Kaaij et al. 2016). Hence, a 
major goal in the future should be to determine if the PE chromatin signature 
is evolutionary conserved among pluripotent cells in vertebrates and whether 
this signature also poises the anterior neural fate in vivo. 
 
mESCs grown under serum+LIF conditions, that we use as in vitro model 
resemble the epiblast cells of mouse E4-5-E6.5 embryos in vivo. Therefore, in 
order to determine whether PEs exist in vivo based on the presence of their 
unique chromatin signature, we propose to perform ChIP-seq for co-activators 
and histone marks in epiblast cells directly isolated from mouse embryos. 
However, for a TF or a co-activator like p300, ChIP-seq requires millions of 
cells, which would be very difficult to obtain for the mouse epiblast. In order to 
solve this problem, Assay for Transposase-Accessible Chromatin (ATAC-seq) 
(Buenrostro et al. 2015) could be performed instead. This technique allows to 
identify low nucleosome occupancy regions in the genome, thus reflecting 
binding of TFs and/or co-activators, but requires much less material (<5x104 
cells). In addition to being bound by TFs and co-activators, in ESCs, PEs are 
defined by low H3K27ac and high H3K27me3 levels. ChIP-seq for histone 
modifications, as it happen with ATAC-seq, can be also performed with lower 
cell numbers. Importantly, we recently implemented a ChIP-seq protocol that 
enables the generation of histone modification profiles from low abundance 
embryonic tissues (5x104-5x105 cells) (Rehimi et al. 2016). Therefore, we will 
generate ATAC-seq, H3K27ac ChIP-seq and H3K27me3 ChIP-seq data in 
epiblast cells isolated from E6.5 mouse embryos to test whether PEs 
identified in mESCs display a similar chromatin signature in pluripotent cells in 
vivo. 
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If these experiments show that the chromatin signature of PEs is present in 
vivo, the next step would be to evaluate if the contacts between PEs and 
target genes are already established in the epiblast and then maintained in 
the developing forebrain in a similar way to what we observed during mESCs 
differentiation. To investigate the topological organization of PE loci in vivo, 
4C-seq experiments in E6.5 epiblast and E11.5 forebrains will be performed 
using some of the previously investigated PEs as a viewpoints (PE Lhx5 (-
109), PE Six3(-133), PE Sox1(+35)). 	  
In addition to all the foregoing, to evaluate the functional relevance of PEs in 
vivo, these sequences should be deleted in the mouse embryo. To perform 
these experiments, the Alt-R™ CRISPR-Cas9 System (IDT) seems the most 
appropriate, as in principle it should enable us to create PE deletions in 
mouse zygotes by injecting a pair of crRNA oligos flanking the selected PE, a 
tracrRNA oligo and recombinant Cas9 protein. Our goal is to generate a 
mouse line with heterozygous deletions (PE+/- mice) for a couple of PE 
candidates (PE Lhx5 (-109) and PE Wnt8b (+21)). Then, male and female PE 
+/- mice will be crossed and the resulting embryos will be genotyped and 
analyzed at E10.5, a developmental stage at which the target genes of the 
selected PEs are strongly expressed in the forebrain. The expression levels of 
the PE target genes will be evaluated by RNA in situ hybridization as well as 
by RT-qPCR. If these experiments confirm that mouse embryos with PE -/- 
show reduced expression of the PEs target genes in comparison to WT 
embryos, then this fact would strongly support the in vivo relevance of PEs in 
the establishment of anterior neural identity during mouse embryogenesis. 
 
6.2- Mechanism of activation of PEs 
 
In this thesis it has been demonstrated that PEs are crucial regulatory 
elements for the proper induction of the anterior neural differentiation 
program. However, the mechanism by which PEs become active and perform 
their function is not clear yet. ChIP-seq data and motif analyses have shown 
that Zic2 might have a role during PEs activation. Mechanistically, ZIC2 can 
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act as a transcriptional activator that, at least in some cellular contexts, binds 
to and is required for the activation of enhancers (Frank et al. 2015; Ishiguro 
et al. 2007).   Therefore, we hypothesize that, based on its expression pattern 
during AntNPC differentiation, binding profile in mESCs and known in vivo 
functions, ZIC2 might be involved in PEs activation and anterior neural 
induction. 
 
To test this hypothesis we will generate Zic2 homozygous knockout mESCs 
lines and differentiate them into AntNPCs. RNA samples will be taken at day 
0, day 3 and day 5 of differentiation and the expression of the PEs target 
genes will be evaluated and compared with WT cells. If our hypothesis is 
correct, and ZIC2 is necessary for the activation of PEs, then the induction of 
at least some of these genes should be compromised upon differentiation of 
Zic2-/- mESCs. RNA-seq experiments would also allow us to know if the 
induction of PoiAct enhancer target genes is globally affected in Zic2-/- cells 
and therefore more globally assess the importance of ZIC2 as a regulator of 
anterior neural induction. 
 
If the previous set of experiments support the theory of ZIC2 as an important 
activator of PEs and major anterior neural genes, ZIC2, H3K27ac and 
H3K27me3 binding profiles in WT cells would be evaluated. Briefly, we would 
use ChIP-seq for the previous proteins in WT mESCs, day 3 WT AntNPCs 
and day 5 WT AntNPCs. These experiments would determine whether ZIC2 
binding is observed and even increased at PEs that become specifically 
activated during AntNPCs differentiation. If so, Zic2-/- mESCs would be 
similarly used to generate H3K27ac and H3K27me3 ChIP-seq profiles on day 
0, day 3 and day 5 of AntNPC differentiation. A comparison between both cell 
lines would reveal whether the loss of ZIC2 affects the chromatin features of 
PEs in mESCs and, most importantly, the subsequent activation of a subset of 
PEs during AntNPC differentiation.  	  
In order to specifically demonstrate whether ZIC2 is necessary for the 
activation of PEs and their associated AntNPC genes, more experiments 
need to be done. One alternative would be to delete or disrupt the ZIC2 
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binding sites within selected PEs. Once mESC clones carrying these 
deletions are generated, they would be differentiated into AntNPCs together 
with WT mESCs. ChIP-qPCR and RT-qPCR experiments would be performed 
in order to show whether the deletion of ZIC2 binding sites leads to a loss of 
ZIC2 binding and reduce activation of the PE candidates as well as the 
induction of the associated target genes. 	  
Finally, to gain mechanistic insights into how ZIC2 might activate PEs during 
AntNPC differentiation, ZIC2 immunoprecipitations (IPs) in mESC, day 3 
AntNPC and day 5 AntNPC followed by Mass Spectrometry (MS) could be 
performed to identify the proteins interacting with ZIC2 in both mESC and 
AntNPC. Afterwards, and focusing on co-activators interacting specifically with 
ZIC2 in AntNPCs, ChIPs could be performed in WT mESC and WT AntNPC 
to determine whether such co-activators bind to PEs activated by ZIC2.  
Moreover, similar experiments could also be done in Zic2-/- mESCs and Zic2-/- 
AntNPCs, which would reveal whether the recruitment of the co-activators to 
PEs is ZIC2 dependent. Depending on the results obtained from the previous 
set of experiments, additional insights into the mechanisms leading to PEs 
activation might be gained and experimentally tested. 
 
All in all, this project has conclusively demonstrated that PEs play a 
fundamental role in the induction of major anterior neural genes towards 
mESC differentiation. In addition, we have uncovered a new function for 
PRC2 as a facilitator of PEs regulatory activity. Lastly, we have proposed a 
series of experiments in order to evaluate if PEs are also important neural 
gene regulators in vivo as well as to deterimine their mechanism of action.  
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AntNPCs                             anterior neural progenitor cells 
bp  base pair 
b-FGF                                 fibroblast grow factor 
BMP  bone morphogenetic protein 
BSA                                    bovine serum albumin 
BXC  bitorax complex 
cDNA                                  complementary DNA 
CBX                                    chromobox/ chromo domain protein 
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ChIP                                    chromatin immunoprecipitation 
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DNA                                    desoxiribonucleic acid 
DSB                                    double-strand-break 
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